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Development of a systems-level understanding of metabolism is expected have far-
reaching benefits from medicine to ecology to industry, as it will facilitate the 
comprehensive profiling and prediction of metabolic states in organisms of 
interest.  Systematic characterization strategies have thus far been successfully applied at 
the genomic, transcriptomic, and proteomic levels, but downstream regulatory interactions 
have remained comparatively underexplored.  We believe this is largely due to the wide 
sensitivity spectrum required to effect a similarly comprehensive study: the binding 
affinities of known protein-metabolite regulatory pairs span multiple orders of 
magnitude.  The overarching aim of this work was therefore to develop and refine multiple 
complementary methodologies for discovery and characterization of these interactions, and 
to explore the potential mutual relevance such a strategy has with higher-level 
metabolomics studies.  
 
An untargeted metabolomics study of inappetence in spawning salmon compared 
metabolic phenotypes between sea-run Alaskan salmon which do not eat for months at a 
time during the spawning season, and a domesticated cohort which were fed throughout 
their spawning period (Chapter 2).  Two dimensional gas chromatography coupled to mass 
spectrometry was used to determine the metabolite profiles of serum samples.  This 
analysis yielded insights into the high-level metabolic differences between inappetent and 
fed salmon. Structural class-specific changes were identified in metabolite levels in 
inappetent fish that suggest a potentially unique utilization of metabolites during spawning-
induced inappetence.  Also, in stark contrast to previous studies of inappetence in whale 
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sharks, the inappetent salmon’s metabolite profiles were not indicative of a classical 
catabolic starvation phenotype.  These results will provide direction and context for future 
protein- and pathway- level studies of salmonid metabolism, and the methodology can and 
should be applied to other organisms to inform systems-level analysis of metabolism, as is 
discussed in Chapter 5.   
 
In order to directly pursue the goal of enabling broad-scale discovery and characterization 
of protein-metabolite regulatory interactions, an in vitro reaction assay-based pipeline was 
developed to provide a flexible framework for both the validation of putative regulatory 
interactions found via other methods, and the discovery of new regulatory interactions over 
a wide range of binding affinities (Chapter 3).  Guidelines were developed not only for 
implementation of the reaction assay strategy itself, but also for the practical and logistical 
necessities of protein handling when many proteins are to be investigated in parallel.  For 
de novo discovery of regulatory interactions, an iterative library screening strategy was 
developed and investigated using yeast chorismate mutase, which has two well-known 
allosteric regulators, as a proof-of-concept.   
 
Small-molecule microarrays, originally developed for use in drug discovery, were explored 
as a potential platform for high-throughput discovery of endogenous binding interactions 
(Chapter 4).  In the process of successfully reproducing the method validation results of 
previous work, we identified guidelines for reducing background in order to meet the needs 
of our intended use of the assay to screen for relatively weak interactions.  Furthermore, a 
photocrosslinking strategy was proposed and preliminary investigations conducted in an 
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effort to increase the sensitivity of the assay and thereby expand the range of endogenous 
interactions that should be detectable via small-molecule microarray.  We identified 
guidelines for further development of this strategy and future effective implementation of 
small-molecule microarrays as a discovery platform for endogenous binding interactions.   
 
Taken together, the findings of this work provide a methodological framework to increase 
the efficiency and range of study for protein-metabolite regulatory interactions, as well as 
lay groundwork for further expansion of that range, ultimately in service of the future 
development of systems-level metabolic models.  Recommendations for future 
development and pursuit of these investigative strategies are discussed in Chapter 5.  
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Chapter 1: Introduction: Metabolic regulation is a systems-
level phenomenon and a persistent methodological challenge 
 
1.1 Systems biology and modeling 
Systems biology refers to the effort to understand the network behavior of biological 
systems, often involving mathematical modeling informed by experiment1, and 
metabolism refers to all of the chemical reactions taking place inside a cell. In cells, 
“network behavior” encompasses comprehensive information about the genome, 
transcriptome, proteome, or metabolome, potentially including not only how these levels 
interact within themselves, but also with each other. On every level of metabolism, activity 
is regulated by transient ligand-binding events that present a much more finely-tuned and 
complex picture than simply looking at genes or proteins or metabolic pathways2-6). 
 
Current state-of-the-art mathematical modeling methods, not discussed in detail here, have 
proven useful in optimizing metabolic pathways for a given objective parameter7,8. One of 
the most common methods, flux balance analysis, is based on stoichiometric ratios and 
requires a quasi-steady-state assumption. Transcriptomic, proteomic, and metabolomic 
data have been used in such models to assist in predicting fluxes9, but the approach is 
paradigmatically the same. However, downstream metabolic regulation is transient and 
dynamic in nature, and is not adequately captured by these types of models (indeed, this is 
generally not attempted). 
 
True dynamic modeling of metabolic behavior must be rooted in a mechanistic 
understanding of component interactions as well as an understanding of the basic pathway 
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architecture. This will involve incorporating multiple timescale of regulatory information 
and relationships, from the transient (e.g. allostery) to the longer-term (transcriptional 
regulation). The amount of data required to construct such a model is enormous. 
Systematic, high-throughput methods of characterizing component interactions have 
already been undertaken at various levels of metabolism (e.g. genomic, transcriptomic), 
but allosteric regulation is an area that has been comparatively underexplored to date2. A 
similar, systematic analysis of metabolite-level regulation would provide a transformative 
contribution to systems biology because it would allow for a level and precision of dynamic 
modeling that has previously been unattainable. 
 
1.1.1 Metabolomics as a systems biology starting point 
Metabolomics is a high-level approach to studying metabolism focusing on comprehensive 
profiling of the metabolites in a biological sample, which results in a complex, phenotypic 
“fingerprint.”  Such profiling has been previously used to great effect in the medical field 
for biomarker discovery, yielding diagnostic screens that may identify a disease state early, 
or differentiate between subtypes of a given disease, as in cancer10.   
 
Differences in metabolic fingerprint between cohorts can point to areas of metabolism that 
will yield mechanistic insight with deeper study, but the fingerprint itself can only provide 
a suggestive snapshot of metabolism.  Metabolomics methods are particularly useful in 
their ability to give quick access to some information about the metabolism of organisms 
that have not otherwise been widely studied, which may in turn present a starting point for 




1.2 Allosteric regulation 
1.2.1 Physical mechanism 
Allostery refers to a regulatory event wherein an effector molecule binds to a protein in a 
location other than its active site and affects the activity of the protein. This effector is not 
a steric analogue of the substrate (hence, “allosteric”), and can influence the protein’s 
activity positively (in the case of an activator) or negatively (a repressor)11,12.  Early studies 
of allostery primarily defined and discussed it as a phenomenon exclusive to oligomeric 
proteins with identical subunits12,13, and this understanding was later expanded and 
generalized to include monomeric proteins14,15. Allosteric binding sites can be located at 
the interface of an oligomer’s subunits (its conformational coupling termed as “direct”) or 
fully-contained within the structure of a monomer or monomeric subunit (“indirect 
coupling”)15, often exhibiting cooperative binding in oligomeric proteins16-18. The term 
“allosteric” has also been used to describe conformational changes involved in protein-
mediated active transport within a cell, wherein the allosteric effector is also considered 
the substrate19. This differs from the original definition in its emphasis on conformational 
change rather than on the distinction between substrate and effector as the most salient 
characteristic of the phenomenon. For the purposes of this work, the original definition will 
be used, with conformational change being considered a mechanism for the regulatory 
phenomenon rather than its defining characteristic. 
 
Many major proteins, including transcription factors14, carrier proteins17, and enzymes20-
22, are explicitly known to be allosterically regulated. The broad spread of proteins with 
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known allosteric interactions, in itself, suggests the importance of this phenomenon’s role 
in metabolism. Beyond the question of prevalence, allosteric interactions are 
fundamentally different from other forms of regulation – particularly transcriptional 
regulation, which is much more widely-studied. Allostery operates on a comparatively 
short timescale, allowing dynamic fine-tuning of metabolism as opposed to transcriptional 
regulation’s often larger perturbations and significant lag time. It is also particularly 
notable in that it allows direct pathway cross-talk, as opposed to, for example, an indirect 
upstream linkage through shared substrates. The phenomenon’s apparent prevalence2 and 
unique function both support the idea that allosteric interactions are a part of metabolism 
worthy of discovery-based characterization efforts. 
 
Perhaps even more intriguingly, energetic modeling of allosteric interactions16 has led to 
the prediction that significant changes to the magnitude or nature (activation or repression) 
of allosteric interactions could be brought about by relatively small alterations to the 
coupling enthalpy or entropy23. This prediction has been borne out by studies in which 
allosteric interaction affinities were precisely tuned15 or even created de novo24 by minor 
mutations. This mutability of allosteric interactions speaks to the phenomenon’s 
importance from an engineering perspective. Broad characterization of these interactions 
– developing an understanding of the “allosterome” of entire organisms – may yield 
important targets for regulatory tuning in engineered pathways. 
 
Furthermore, the point has been made that in the early days of protein research when effort 
to discover a new protein was on par with the effort required to characterize that protein’s 
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regulatory behavior, most known proteins were known to exhibit allostery; in the past few 
decades, ease of protein discovery has skyrocketed while ease of allosteric characterization 
has not, and the rate of increase in known allosteric interactions is comparatively slow2. 
 
The likely-widespread importance and relative lack of research coverage of allostery in 
metabolism makes the phenomenon an attractive and potentially high-impact area of study 
for systems biology. 
 
1.2.2 Discovery of new regulatory interactions 
Characterization of allostery is, thanks to the generally weak (but exceptionally diverse in 
affinities), transient nature of the interactions involved2, a nontrivially difficult task to do 
in a systematic manner. Historically, allosteric interactions have been discovered and 
characterized during intense study of a single protein or protein family20,22,25, with 
specialized assays designed around the exact system being studied. This is untenable as a 
systems-scale analysis or discovery solution for obvious reasons. 
 
Structure-based mathematical models have been created to describe allosteric interactions 
and attempt to predict them26,27, but these models have not thus far been successfully 
implemented as tools of discovery. Machine learning has also been proposed as a technique 
to predict “allosteric hot spots”28; the accuracy of the results did not, however, indicate that 




Several experimental strategies have been implemented in recent years to identify protein-
metabolite binding interactions. A limited in vivo analysis of kinase regulation in yeast has 
shown promise as a methodology and identified ergosterol as a promiscuous binder and 
potentially important regulator5. Similarly, different mass spectrometry-based in vitro 
approaches have been used to study lipid-protein interactions3,4  and small metabolite-
protein interactions6. The latter method used equilibrium dialysis to partition metabolite 
solution into different chambers containing or lacking a protein of interest and measured 
the enrichment of the metabolite in the protein-containing partition. This technique 
currently requires a large amount of protein (on the order of 1 mg per assay, approximately 
the total yield from a liter of culture with a “high expression” yeast ORF from the library 
that was used in this research29), limiting its potential for extremely high-throughput usage. 
The former two methods made use of affinity interactions to immobilize a protein of 
interest on a solid matrix, then either eluted off metabolites bound in vivo5 or in an in vitro 
incubation step3,4,6. The primary restriction that these methods have in common is that the 
protocols were optimized for detection of very specific classes of metabolites. The in vivo 
approach also, at present, requires an extremely expensive detection platform due to the 
small individual concentrations of the analytes.   
 
Another family of strategies is based on the thermodynamic stabilizing effect on proteins 
of metabolite binding, tracking protein destabilization in lysate or with a chemical 
denaturant, such as in Stability of Proteins from Rates of Oxidation (SPROX)30,31.  In these 
assays, proteins are incubated with known metabolites and their stability is tracked relative 




Other methods, such as small molecule-affinity chromatography combined with stable 
isotope labeling of amino acids in cell culture32, have used metabolites as the capture 
reagents, resulting in a search that runs in the opposite direction from the strategies 
described above (i.e., beginning with a metabolite that is desirable to investigate, rather 
than a protein).  These methods have increasing popularity, but the disadvantage of 
requiring that the metabolites be modified.  Also under the “metabolite-first” umbrella are 
chemoproteomic approaches, which allow detection of interactions in live cells by 
modifying the probe metabolite to be able to covalently modify its protein target33.   
 
The diverse array of experimental strategies for interaction discovery reflects the large 
degree of variability in both structural and practical specifics of these interactions.   
 
1.3 Saccharomyces cerevisiae 
The yeast S. cerevisiae was chosen as the primary organism of study for the direct protein 
investigations in this work because it is commonly used both as a model eukaryotic 
organism and a metabolic engineering workhorse. Its relative ease of culture, fast doubling 
time, and possession of eukaryotic chaperone proteins make it an attractive early-stage 
analogue for studying eukaryotic metabolism in general, and its approximately 6000-gene 
genome is comparatively small and simple versus that of higher eukaryotes. From an 
engineering perspective, these traits make S. cerevisiae a convenient host for many 
metabolic engineering efforts34,35, and from a biological perspective, perhaps the easiest 
eukaryotic model to work with. Furthermore, much of the currently-existing genomic and 
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transcriptomic data are readily available in aggregate in internet databases36,37. S. cerevisiae 
is therefore an attractive choice for development of methods for characterization and 
discovert of protein-metabolite interactions, as the information gained will be applicable 
both in theory and in direct practice. 
 
1.4 Thesis overview 
Systematic collection, assembly, and integration of protein-metabolite regulatory data 
would provide a much-needed level of detail in pursuit of effective, dynamic modeling of 
metabolism - a major goal across multiple subdisciplines.  Many strategies have been 
developed and implemented over the past ten years, with varying degrees of ambition 
regarding throughput and scope, but no single methodology or pipeline has thus far 
provided a true framework for comprehensive study.   
 
The purpose of this work was originally intended to be the development of such a single, 
comprehensive pipeline for characterization of regulatory interactions.  However, it has 
become increasingly clear both in the course of this work and through the work of other 
researchers within the last handful of years that for the present, a mosaic of methodologies 
is necessary in order to account for the sheer variety represented in such interactions.  This 
thesis, then, attempts an integrative view of studying regulation at the metabolite level, 
which takes into account that variety and addresses differing practical concerns that may 
emerge from it.   
 
1.4.1 High-level insights from untargeted metabolomics 
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As described above, high-level metabolic differences between cohorts of a single organism 
can be suggestive of areas of interest for systems-level study.  They indicate a metabolic 
response to perturbation, a significant part of which may take place at the protein-
metabolite interaction level.  The results of our early metabolomics study of Atlantic 
salmon were not further pursued in such a manner in this work, but nevertheless provide 
important context for a deeper study of protein-metabolite level metabolic regulation. 
 
Wild Atlantic salmon exhibit inappetence during spawning.  Studies with other organisms 
that display similar behavior have indicated a pathological metabolic state; this study was 
intended to see if Atlantic salmon had a similar metabolic response to inappetence, and to 
simply identify high-level changes in metabolism that correspond with a prolonged period 
of inappetence.   
 
Control fish were hatchery-raised, and fed throughout their spawning period, and compared 
to sea-run salmon which undergo a period of inappetence as long as half a year.  Serum 
samples were taken from each cohort and analyzed using two-dimensional gas 
chromatography coupled to time-of-flight mass spectrometry (GCxGC-TOFMS), yielding 
metabolite profiles which were then further investigated using statistical methods to 
identify the metabolite differences that represented a significant source of variation 
between the two cohorts.   
 
1.4.2 A pipeline framework for medium-throughput investigation of enzyme regulation 
via direct reaction assay 
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Sensitivity restrictions and other practical limitations of screens for protein-metabolite 
binding interactions present a gap in currently-implemented systematic strategies for 
regulator discovery.  Furthermore, all screening methods that identify binding interactions 
or putative binding interactions require downstream validation and characterization via 
reaction assay, and this step is too-often an afterthought in current literature.  We developed 
an expression-to-characterization reaction assay pipeline to facilitate validation of potential 
regulators in future studies, and to simultaneously address the strategic gap in de novo 
discovery.   
 
Three S. cerevisiae proteins of diverse reaction chemistry were chosen from a 
commercially-available yeast protein library for development case studies.  Induction 
behavior was characterized over and beyond typically-recommended ranges of induction 
density.  Then, the enzymes’ relative reactivity was assayed over three different reaction 
assay architectures.  Finally, a set of reaction assays using chorismate mutase and its two 
known allosteric regulators was used to provide proof-of-principle for our proposed 
library-based screening strategy for de novo regulator discovery. 
 
1.4.3 Challenges and potential of small-molecule microarrays for interaction discovery 
Development of an effective high-throughput screening strategy for protein-metabolite 
binding interactions is a highly desirable goal in the study of metabolic regulation.  We 
explored the use of small-molecule microarrays, previously developed with an eye toward 
high-throughput drug discovery, as a potential platform for such a high-throughput screen 




Small-molecule microarrays were synthesized from amino-silane functionalized glass 
slides using isocyanate-based covalent attachment chemistry, producing an array of spotted 
metabolites tethered to the solid substrate via a short polyethylene glycol linker.  Protocols 
for probing with a protein of interest were tested and adjusted with an eye to the challenges 
of screening for endogenous interactions (namely, since most allosteric interactions have 
binding strengths in a range that makes it particularly necessary to minimize fluorescence 
background on the hybridized slides).  Finally, a novel strategy of photo-inducible 
crosslinking was explored as a potential means of increasing the sensitivity of the assay. 
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Chapter 2: Untargeted metabolomics yields insights into high-
level metabolic differences in two Atlantic salmon cohorts 
 
This chapter is largely taken from “Differential metabolite levels in response to spawning-
induced inappetence in Atlantic salmon Salmo salar,”1 which was published in 
Comparative Biochemistry and Physiology, Part D.  All experimental design, handling of 
fish, and collection of serum samples was conducted by authors Rocco C. Cipriano and 
Alistair D.M. Dove.  Sample work-up and analysis by gas chromatography-mass 
spectrometry was conducted by McKenzie L. Smith, and data processing/statistical 
analyses were conducted by McKenzie L. Smith and Kathleen A. Vermeersch, both under 
the advisement of Mark P. Styczynski. 
 
2.1 Introduction 
The salmonid family includes cool temperate anadromous fishes, including many species 
of important commercial and conservation concern such as Atlantic salmon Salmo salar 
(S. salar). All salmonid fish experience conditions of extreme physiological change over 
the course of their lives, including the shift from freshwater to seawater and subsequently 
back to freshwater for spawning. In addition, there are also extended periods with little to 
no active feeding during overwintering and during the spawning run. One might generally 
expect that extended periods of inappetence could have a deleterious impact on an animal, 
which could in turn be detected via circulating biomarkers; perhaps the most well-known 
example of this is ketosis and acidosis in humans, which can occur in response to starvation 
or prolonged fasting. It was recently found that inappetent whale sharks could be 
distinguished by circulating biomarkers, including markers such as keto-acids that are 
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similar to those expected in human starvation2. However, it is not known if inappetence of 
during migration and spawning could even be attributed to or distinguished by some form 
of abnormal physiology. It is unclear whether long-term inappetence is an inherently 
stressful event (and thus potentially dangerous as it could compound the effect of 
anthropogenic stressors), or whether this is a natural condition that the fish have evolved 
or adapted to efficiently handle during their regular life cycle. Characterizing and 
understanding the response of salmonid fish to such an extreme condition may provide 
insight into the physiology of all fishes and the potential challenges faced by some 
important endangered populations during their complex life histories. Taken together, these 
insights may help enable more efficient monitoring of these species, with broader economic 
impact via the extensive efforts of federal and state wildlife management agencies. 
 
Part of the challenge of exploring these potentially stressful physiological changes over the 
lives of these fish is in the overall lack of biochemical knowledge about the animals. A 
common approach in veterinary and husbandry practice is to measure serum or plasma 
levels of molecules with already-known clinical significance in the specific species under 
study3,4, or molecules with known significance in other model species that are expected to 
be important in the species under study5-7. However, it is generally unknown what the 
serum levels of a given metabolite (e.g., glucose or free fatty acids) should be in normal 
versus different diseased or affected states for an arbitrarily-chosen species of fish. To this 
end, discovery-oriented approaches are particularly valuable to begin to understand the key 




There has been increasing use of high-throughput, systems scale (“-omics”) technologies 
to assess the physiological state of salmonids under different conditions. Functional 
genomics approaches have studied the transcriptional changes in the liver and other tissues 
of salmonids8-10. There has also been some recent attention to exploration of salmonid 
physiology through the systematic measurement of small-molecule biochemical 
intermediates (metabolites) in the field known as “metabolomics”11-15.  The majority of the 
focus in such studies has been on the toxicological and environmental impacts on the fish, 
including petrochemicals12 and pesticides15. While the study of such anthropogenic sources 
of disturbance to the salmonid life cycle are obviously of value, a better understanding of 
the salmonid’s response to natural life cycle events would help to provide a more detailed 
picture of salmonid physiology and biochemistry, as well as suggest whether these life 
cycle events might compound the effects of anthropogenic stressors. 
 
Recently, there was one metabolomics study of a salmonid response to short-term fasting, 
in juvenile rainbow trout Oncorhynchus mykiss16. That study used proton nuclear magnetic 
resonance (NMR) spectroscopy to measure metabolite levels in plasma, liver, and muscle 
extracts, and found significant changes in lipids and energy metabolites in these samples. 
However, the authors noted that using hatchery-reared fish under laboratory conditions 
may limit generalization of the results, as wild fish are usually leaner and may have 
different responses to fasting. Additionally, the scope and number of analytes studied (due 
to sensitivity requirements and limitations on analyte identification with an NMR-based 
approach) was limited. Finally, that study involved a 28-day fasting experiment that did 
not include the impact of the months-long inappetence that salmonids experience during 
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spawning and overwintering. A subsequent study used mass spectrometry in place of 
NMR, but did not address the other limitations17. 
 
The purpose of this work is to test whether there are indications that long-term inappetence 
of salmon is a pathological state as in other organisms, and to explore the changes in blood 
metabolite profiles caused by long-term inappetence. These goals are accomplished using 
a highly sensitive mass spectrometry-based approach to compare differences in blood 
metabolite levels between the same generation of hatchery-raised and -fed control fish as 
compared to wild, sea-run fish fasting for five to six months. Serum samples were taken 
from each of these corresponding cohorts and then analyzed to identify biochemical 
indicators of response to inappetence. 
 
 
2.2 Results and discussion 
2.2.1 Overall data set and reproducibility 
The inappetence of returning spawning Atlantic salmon is a profound physiological change 
hypothesized to be reflected in their serum metabolite levels. Metabolite profiling using 
two-dimensional gas chromatography coupled to mass spectrometry supports this 
hypothesis. Overall, 139 analytes were retained after quality control filtering (Figure 2.1), 
including unknown and known analytes and with the potential of having multiple 
derivatization peaks for the same analyte. Known analytes were only identified as 
metabolites if they had entries in HMDB (used as a proxy for general biological validity, 
though potentially omitting some xenobiotics). Technical duplicate measurements showed 
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high reproducibility; the average pairwise (Pearson) correlation coefficient of duplicate 
measurements was 0.96. Of this set of reproducible analytes, 57 were resolved to unique, 
identifiable metabolites; this reduced set of analytes had an average pairwise correlation of 
0.97. 
 
Figure 2.1: Heatmap of all normalized metabolite levels. Log-transformed and autoscaled metabolite peak 
areas presented in heatmap format for all measured analytes (including those not assigned identities during 
data analysis). Red entries indicate higher metabolite levels, blue indicates lower levels. Sample classes are 
indicated on the left by color code (red for domesticated, green for sea-run), and metabolites are organized 





2.2.2 Multivariate analysis of the metabolite profiles of the fasting and feeding fish 
Gross changes in metabolic physiology were easily detectable using principal components 
analysis of the entire set of measured analytes (Figure 2.2). The second principal 
component was the dominant axis of variation in determining the nutritional status of any 
given animal. The first principal component predominantly reflected a batch effect that was 
not able to be completely removed via data normalization (Figure 2.3). However, the 
combination of these two principal components (essentially allowing the second 
component to provide separation relative to the first component) provides almost perfect 
separation between the two sample classes. There are two notable outliers in the data: both 
technical replicates for sample 23, a fasted animal that clustered with the fed animals. This 
misclassification is consistent across all subsequent data analyses; it is unclear whether this 
is the result of a mislabeled tube, whether this animal had somehow eaten at some time 
pre- or post-spawning, or whether that animal just had such substantial biological variation 
from the rest of its cohort. Limiting analysis to only the identified metabolites, PCA 







Figure 2.2: Principal components analysis shows strong separation between domesticated and sea-run 
fish. Unsupervised dimensional reduction using all measured analytes yields separation in just two principal 
components. The first principal component mostly captures a sample-ordering-based batch effect that could 
not be removed by data normalization approaches. The second principal component is the dominant axis of 
separation between the two classes, after accounting for batch-related differences. Red markers represent 
domesticated fish, green markers represent sea-run (inappetent) fish, and the dotted circles represent 95% 
confidence regions on the respective sample classes. Axes also indicate the fraction of overall variation 





Figure 2.3: PCA visualization of batch effects. Due to an instrumentation issue during data acquisition, 
two batches of samples (1 and 5) exhibited batch effects evident during principal components analysis. Note 
that for each batch (indicated by different colors on the plot), principal component 1 predominantly represents 
the batch effect (though some fish sample class effect is also included in this principal component). Principal 
component two, as indicated in the main text, predominantly captures the differences between sample classes, 








Figure 2.4: Unsupervised dimensional reduction yields separation in just two principal components. 
The first principal component mostly captures a sample ordering-based batch effect that could not be removed 
by data normalization and quality control. The second principal component is the dominant axis of separation 
between the two classes, after accounting for batch-related differences. Only identified metabolites (see 
Methods) are used for this analysis. Red markers represent domesticated fish, green markers represent sea-
run (inappetent) fish, and the dotted circles represent 95% confidence regions on the respective sample 
classes. Axes also indicate the fraction of overall variation capture by each principal component. 
 
This unsupervised principal components analysis indicates that once a sample-ordering 
batch effect was accounted for, one of the dominant modes of natural variation in the data 
was controlled by the fed vs. fasting condition of the animals. The fact that separation 
occurred naturally in this unsupervised approach in the first two principal components 
suggested that the differences that were being measured were real and biologically relevant. 
PLS-DA supported this finding (Figure 2.5): the two classes of animals, with the exception 
of the previously noted outliers, were clearly separated in only one component. 10-fold 
cross-validation yielded a Q2 value of 0.82 in two components. The separation was 
significant with a p < 0.0005 using a label permutation test with two components. Again, 
performing the same analysis using only the putatively identified metabolites yielded 
24 
 
similar visualization results with similar statistical significance and cross-validation scores. 
The metabolites identified as most important in the PLS discriminating axis were largely 
the same as the metabolites that were individually statistically significant, and so those 
individually significant metabolites will be considered further below. 
 
Figure 2.5: Partial least squares discriminant analysis shows strong separation between domesticated 
and sea-run fish. Strong separation between the two classes can be seen in only one dimension using a 
supervised dimensional reduction approach including all measured analytes. Red markers represent 
domesticated fish, green markers represent sea-run (inappetent) fish, and the dotted circles represent 95% 
confidence regions on the respective sample classes. 
 
2.2.3 Significantly different analytes between fasting and feeding Atlantic salmon serum 
Of the 137 overall consistently measured analytes, 58 were identified as significantly 
different between the sea-run inappetent and the domesticated feeding fish (t-tests with p 
< 0.05 after false discovery rate correction18. Of the 57 analytes resolved to unique, 
identifiable known metabolites, 27 of these were found to be significantly different 
between the sea-run inappetent and the domesticated feeding fish (Table 2.1). However, an 
inherent limitation of this study is the confounding effect of diet on serum levels. It is well-
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known that having a high level of a specific metabolite in a food can cause elevated levels 
of that nutrient in the serum. For example, increasing levels of eicosapentaenoic acid in 
feed was shown to increase serum levels of eicosapenatenoic acid19.  (However, this is not 
universally true; in that same study, increasing levels of alpha-linolenic and 
docosahexaenoic acid did not change serum levels of the respective molecules.) 
Nonetheless, to avoid any potential confounding factors, it is most prudent to focus on the 
analytes that increased in the inappetent fish; these are very unlikely to be artifacts of the 
feeding regimen. 
Table 2.1: Significantly different metabolites between domesticated and sea-run fish. Only analytes with 
metabolite identities assigned during data processing (see Methods) are presented; when multiple 
derivatization products for the same metabolite were identified, the analyte with the fewest missing values 
across the samples and QCs was selected as representative for that metabolite. Fold changes are log2, with 
negative values indicating depletion in sea-run fish and positive values indicating accumulation in sea-run 
fish. p-values are after false discovery rate multiple hypothesis correction; only metabolites with p-
values < 0.05 are presented. 




Gondoic acid 1.98 1.92E − 10 
Erucic acid 2.82 3.75E − 10 
L-Alanine − 0.72 3.21E − 07 
Eicosapentaenoic acid − 0.46 9.61E − 07 
L-Valine − 0.40 9.61E − 07 
Putrescine − 0.70 9.61E − 07 
myo-Inositol − 0.60 2.10E − 06 
L-Leucine − 0.50 8.88E − 06 
ɤ-aminobutyric acid − 1.61 8.02E − 05 
Myristic acid − 0.58 1.07E − 04 
(S)-3-Hydroxyisobutyric acid − 0.38 1.36E − 04 
Docosahexaenoic acid − 0.30 2.57E − 04 
L-Tyrosine − 0.35 4.70E − 04 
2-Methyl-3-hydroxybutyric acid − 0.63 0.0014 
L-Isoleucine − 0.38 0.0019 
4-Hydroxyproline 0.47 0.0021 
Palmitoleic acid − 0.52 0.0021 
Fumaric acid − 0.48 0.0025 
D-Glucose − 0.57 0.0041 
Scyllitol 0.53 0.0041 
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Table 2.1 (continued) 
N-Acetyl-D-glucosamine − 0.49 0.0052 
L-Methionine − 0.99 0.0053 
D-Fructose − 0.53 0.0066 
D-Tagatose − 0.58 0.0087 
α-Linolenic acid − 0.23 0.028 
Ribitol 0.16 0.029 
2-Hydroxy-3-methylbutyric acid − 0.44 0.04 
Nervonic acid 0.85 0.043 
 
2.2.4 Significantly accumulated analytes in inappetent Atlantic salmon serum 
Of the 27 significantly different analytes between feeding and inappetent fish, only 6 were 
accumulated in the inappetent fish; the remainder were all depleted in the inappetent fish. 
This is perhaps not unexpected, as continuing inappetence to the point of starvation may 
deplete the blood of many nutrients, limited by the rate at which nutrients can be mobilized 
from storage and other tissues. If this is true, it suggests that the six metabolites that were 
accumulated may be particularly interesting. Of those six, three were ω-9 monounsaturated 
fatty acids (erucic acid [22:1ω9], gondoic acid [20:1ω9], and nervonic acid [24:1ω9]), and 
two were sugar alcohols (scyllitol and ribitol). Interestingly, no ω-9 monounsaturated fatty 
acids were found to be depleted. The two sugar alcohols represented half of the annotated 
sugar alcohols detected in this study. The other two sugar alcohols that were not increased 
in inappetent fish (myo-inositol and glycerol) have well-known signalling and lipid 
transport roles which may help to explain why they did not change in register with the rest 
of the sugar alcohols. 
 




Long-term inappetence or starvation is a phenomenon that has been shown to have a 
significant effect on the physiology of an organism. It has been proposed that the starvation 
process goes through three phases, typically associated first with high metabolism of 
glycogen, followed by predominant use of lipids for energy generation, and finally ending 
in use of proteins for energy generation20. This often results in changing levels of lipids, 
proteins, and the metabolites in blood. One common response during this second phase, 
catabolism of fatty acids, is the generation of ketone bodies that elevates circulating ketone 
levels. While this is a well-known and common response in endotherms, in ectotherms 
there is not evidence for an increase in circulating ketone bodies. 
 
In their metabolomic study of whale sharks2, Dove et. al detected seven keto-acids that 
were more prevalent among samples from pathologically inappetent whale sharks than 
from animals that were feeding normally. These acids were interpreted as representing a 
catabolic state wherein the inappetent whale sharks were breaking down their own tissue 
proteins and liberating different ketone species into the circulation. Interestingly, the 
current study did not detect a pronounced keto-acid pattern among inappetent despite 
known protein breakdown during salmon inappetence, for which three possible 
explanations have been identified. First, the analytical techniques differed between the two 
studies (direct MS for whale sharks, GCxGC-MS for Atlantic salmon) and may differ in 
sensitivity to keto-acids. However, keto-acids should generally be measurable by GC-MS 
and several keto-acids have previously been detected and tracked on the specific instrument 
used. Since the keto-acids were infrequently detectable in healthy samples from the whale 
sharks, this further suggests that the reason they were not observed in either set of fish may 
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be that they were not present. Second, there may be profound differences in response to 
pathological inappetence between sharks and salmon, where acidosis/aciduria is induced 
in one but not the other. Third, and probably most likely, there is a real metabolic difference 
between pathological inappetence in the whale sharks and adaptive or “normal” 
inappetence in the spawning run Atlantic salmon. This would imply that Atlantic salmon 
may have evolved tolerance to the prolonged anorexia during the spawning run, which 
would probably not come as a surprise. 
 
 
2.2.6 Fatty acid metabolism response to inappetence appears to be dependent on fatty 
acid structure 
The ω-9 monounsaturated fatty acids that were found to be accumulated in inappetent fish 
were reucic acid, gondoic acid, and nervonic acid; these are of particular interest due to the 
specificity of their behavior and the strength of their signal. Gondoic acid and erucic acid 
exhibited the two most significant and largest magnitude changes of all annotated 
metabolites (approximately 4-fold and 8-fold changes, respectively), suggesting a 
particularly important or unique role in the physiological response to starvation. While 
three measured ω-9 monounsaturated fatty acids were accumulated in inappetent fish, all 
three ω-3 polyunsaturated fatty acids were found to be depleted in inappetent fish 
(eicosapentaenoic and docosahexaenoic acids with p < 0.001, α-linolenic acid with p < 0.05 
after FDR correction; Figure 2.6). Again, these measurements may be confounded by the 
feeding regimen of the control fish, which contains fish meal and thus is high in fatty acids. 
Nonetheless, previous studies showed changes of less than 50% in blood fatty acid levels 
for increased feeding content of docosahexaenoic and eicosapentaenoic acid from 0% to 
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2% of dry weight, which is consistent with the observed levels in this work19. (Unless 
indicated, this and all other referenced literature did not use exclusively female fish.) 
Importantly, these changes are substantially different from the 8-fold, 4-fold, and 2-fold 
increases observed in the ω-9 fatty acids.  Thus, while the specific interpretation of ω-3 
polyunsaturated acids cannot be distinguished as being diet-related or inappetence-related, 
it is clear that they are nowhere near the strongly accumulated status of the ω-9 
monounsaturated acids. The mechanism for such specific regulation or utilization of certain 
unsaturated fatty acids remains unclear, but is noteworthy, particularly in light of previous 





Figure 2.6: Fatty acids exhibit structure-specific differences between domesticated and sea-run fish. 
The ω-9 monounsaturated fatty acids measured (top row) exhibited significant changes between domesticated 
and sea-run fish that were in the opposite direction of the ω-3 polyunsaturated fatty acids (bottom row), 
suggesting some structure-specific utilization of fatty acids in response to prolonged inappetence. Red 
represents domesticated fish, green represents sea-run fish. Colored bar represents the span of the middle 
50% of samples, with the median represented by a dark black line within the colored bar. Error bars show 
two standard deviations, with outliers represented as circles. Values are log transformed and autoscaled. 
Asterisks indicate FDR-corrected p-values: *p < 0.05, **p < 0.0005, ***p < 10− 6. 
 
It is well-known that fatty acids are mobilized from the liver and from muscle tissue in 
response to extended periods of starvation in fish21. Previous work studying fasting in a 
different salmonid species16 found clear tissue-specific mobilization patterns of lipids and 
some degree of structure-specific changes in lipid concentrations. Specifically, serum 
levels of unsaturated lipids increased after 28 days of fasting, while other measures of 
serum lipid levels either increased or decreased. A related study by Baumgarner and 
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Cooper found many saturated fatty acids to decrease after 28 days, but also saw 
docosahexaenoic acid decrease17, in contrast with the prior result. General analysis of free 
fatty acids, regardless of saturation, has shown decreases in plasma levels22.  Other work 
by Pottinger and colleagues saw increases in plasma free fatty acids in the first two months 
of starvation, followed by a decrease in serum free fatty acids23. 
 
This work refines this analysis further, identifying not the general class of unsaturated 
lipids as increasing in fasted fish serum, but specifically ω-9 monounsaturated lipids as 
increasing while ω-3 polyunsaturated lipids decrease. Both 18:1 (ω-9) and 20:1 (ω-9) have 
been shown to be mobilized from liver and muscle stores during fasting24, with 18:1 (ω-9) 
fatty acids being the most readily used energy source in teleosts25. However, this study 
finds no significant change in 18:1 (ω-9) serum levels, while significant increases in 20:1 
and 22:1 fatty acids are observed. Alternatively, after such an extended period of 
inappetence, the ω-3 fatty acids may be so depleted due to lack of intake (they are essential 
fatty acids) that the salmonid is producing more of the ω-9 fatty acids to make up for the 
deficiency for any functions that may be amenable to either type of molecule. 
 
Overall, these results suggest an important or unique role for unsaturated fatty acids in the 
physiological response to prolonged starvation. While the unsaturated fatty acids split 
structure-specifically between accumulation and depletion in long-term inappetent fish, 
saturated fatty acids show no such strong signal. Of the 10 saturated fatty acids measured 
in the serum samples, only two are significantly changed, with palmitic acid increasing and 
myristic acid decreasing in inappetent fish. The ω-9 fatty acids may be playing a critical 
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role in mobilizing energy sources from liver and muscle; previous work has found this to 
be true for muscle levels of one ω-9 fatty acid16, which could cause higher serum levels of 
these acids if this is indeed occurring. However, it is also possible that unsaturated fatty 
acids are being non-specifically mobilized from tissue stores, with the ω-9 fatty acids not 
being utilized as heavily and thus essentially accumulating. 
 
2.2.7 Polyol accumulation might be indicative of a currently unknown response to 
starvation 
The strong changes in polyols are also of note. Polyols are generally known to serve as 
osmolytes with potential cryoprotectant capabilities26. However, there is fairly little known 
about polyol levels in fish.  The accumulated polyol scyllitol was first discovered in sharks 
and skates in 1858 by Staedler and Frerichs27,28.  It is known that skates have the highest 
levels of scyllitol in their kidneys and livers. Scyllitol is an osmolyte known to be present 
in the blood of teleosts and other deep-sea animals and which may function as a 
cryoprotectant29,30. It has also received significant interest for its role in brain chemistry 
across species from fish to mammals, and in particular for its potential as a therapeutic for 
Alzheimer’s disease, likely related to its stabilization of and interaction with proteins27,28. 
The relevance of these increased sugar alcohol levels, particularly as related to prolonged 
starvation, warrants further study, as this may reflect an unknown metabolic or biochemical 
response to starvation that has not previously been characterized. 
  
2.2.8 Amino acids supply additional energy sources to fasting 
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Branched-chain amino acids (BCAAs) are another noteworthy set of metabolites. Three of 
the fifteen most significant changes were in the BCAAs valine, leucine, and isoleucine, 
which were all depleted; this is consistent with previous results from short-term 
inappetence in domesticated rainbow trout17. Taken together, BCAAs have an important 
role in continued energy generation after depletion of muscle glycogen stores31. Amino 
acids, as breakdown products of muscle protein, are the major source of energy for fish 
during extended starvation32,33. In fact, though, many different amino acids can be 
transformed into the anaplerotic biosynthetic intermediates needed to sustain oxidative 
phosphorylation and gluconeogenesis34. A general utilization of proteolysis for energy 
production thus could potentially lead to a general decrease in serum amino acid levels, 
with the post-glycogen depletion role of BCAAs potentially leading to their even further 
and more specific uptake and use. This is particularly relevant here, as only 60% of the 
measured proteinogenic amino acids were found to be depleted in inappetent fish. As noted 
above, interpretation of these results may be limited based on the potential confounder of 
diet. However, a number of factors suggest that the effects observed may not be totally 
diet-related. First, the results are, as described above, consistent with multiple previous 
studies that did not have potential diet confounders17,35. Second, the control fish feed was 
high in protein, yet only some of the amino acids were depleted in the inappetent fish, 
suggesting something more complex than just food-related elevation of serum amino acid 
levels in control fish. 
 
Looking more broadly at amino acid metabolism, even more changes are seen in response 
to inappetence. Alanine was the third-most significantly altered metabolite (and the most 
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significant depleted metabolite), consistent with previous work identifying changes in 
alanine in response to short-term inappetence in rainbow trout17. However, neither glycine 
nor serine previously reported in domesticated, short-term inappetence were observed here, 
though the general trends of amino acid depletion were consistent. Pathway-level analysis 
using MetaboAnalyst identified a number of significantly altered pathways (Table 2.2), 
where among the most significant with the most support (in terms of numbers of analytes 
detected) were several specific amino acid metabolism pathways beyond the BCAAs (all 
FDR-corrected p < 10-4). This supports the idea of significant alterations in amino acids 
and their biosynthetic intermediates in the blood of inappetent animals. 
Table 2.2: Significantly enriched pathways from MetaboAnalyst pathway analysis. P-values are false 
discovery rate corrected. 
Pathway p-value 
Arginine and proline metabolism 2.89E-09 
Biosynthesis of unsaturated fatty acids 4.23E-09 
Selenoamino acid metabolism 2.50E-07 
Aminoacyl-tRNA biosynthesis 3.22E-07 
Alanine, aspartate and glutamate metabolism 3.22E-07 
Valine, leucine and isoleucine degradation 5.43E-07 
Pantothenate and CoA biosynthesis 5.43E-07 
Inositol phosphate metabolism 1.27E-06 
Ascorbate and aldarate metabolism 1.27E-06 
Valine, leucine and isoleucine biosynthesis 4.98E-06 
Galactose metabolism 1.91E-05 
Butanoate metabolism 0.000114 
Tyrosine metabolism 0.000118 
Glutathione metabolism 0.000151 
Fatty acid biosynthesis 0.000289 
Ubiquinone and other terpenoid-quinone biosynthesis 0.000297 
Phenylalanine, tyrosine and tryptophan biosynthesis 0.000876 
Phenylalanine metabolism 0.000876 
Cysteine and methionine metabolism 0.00311 
Starch and sucrose metabolism 0.00321 





2.2.9 Limitations of this study 
While the approaches used to probe for changes in metabolic status in inappetent fish 
comprise a powerful framework for veterinary, husbandry, and scientific analyses, there 
are certainly limitations to this framework. The metabolite measurements were only semi-
quantitative, enabling comparison between groups but not absolute quantitation of 
concentrations (highlighted by the inclusion in principal component one of batch effects). 
Future efforts should focus on including more spike-ins of labeled compounds along with 
the establishment of calibration curves to attempt to facilitate absolute quantitation. 
However, since each group had the same amount of serum assayed on the GCxGC-MS, 
direct comparison of the semi-quantitative results is still valid. In fact, the univariate results 
likely underestimate potential differences between the groups, as the observed slight batch 
effect only makes the measured differences less statistically significant. In addition, the 
fact that only serum was assayed – not the metabolite levels in liver, muscle, or any other 
potentially relevant tissue – limits the scope in interpreting measurements in a biochemical 
pathway context, as blood is essentially an integrative biomarker across the entire organism 
due its interaction with all tissues. Ongoing work measuring metabolite profiles in specific 
tissues is expected to help enable a more direct interpretation of the results shown here.   
 
Finally, the fact that the control fish were domesticated rather than sea-run adds a potential 
confounder to the analysis that cannot be decoupled. Certain aspects of this issue are 
impossible to remedy through a control; for example, it is impossible to use a fed sea-run 
fish control because only domesticated fish can be made to feed leading up to spawning. 
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One would expect the long-term feeding patterns dictated by location, activity, and other 
factors to be different between a fed captive and fed sea-run group before any inappetence, 
which could contribute to some of the observed differences; however, since going over six 
months without food is such a significant perturbation, it is reasonable to expect that the 
inappetence and resulting mobilization of other energy resources would dominate the 
baseline differences between the animals. Additionally, the sea-run fish had already 
traveled approximately 75 miles upstream before being captured and held for six months 
while the domesticated fish had not, which could contribute more to the depletion of 
resources and metabolic changes in these animals. Again, based on the fact that non-
domesticated spawning fish cannot be fed, this is another phenomenon that cannot be 
decoupled. However, this is an intrinsic and important part of spawning-induced 
inappetence, so the combination of these two factors is ultimately reasonable.  
 
2.3 Conclusions and context 
This study identified interesting, structural class-specific changes in serum metabolite 
levels in inappetent spawning fish. ω-9 fatty acids were specifically accumulated in 
inappetent fish, in stark contrast to the majority of significantly changed metabolites, 
including the ω-3 free fatty acids. This observation, combined with the significant 
depletion of branched chain amino acids, suggests a possibly uncharacterized unique and 
specific utilization of metabolites in the long-term stress of spawning-induced inappetence. 
The significant accumulation of sugar alcohols in the serum was another unexpected 
observation that is not explainable based on current knowledge of salmonid biochemistry, 




The mass spectrometry-based strategy used here has shown to be powerful at identifying 
specific molecules and classes of molecules that change in response to a long-term natural 
potential stressor of health. Characterizing and understanding the physiological responses 
of salmonid fish to extreme conditions may provide insight into the natural physiological 
variability of and the physiology of all fishes, which could in turn serve as a starting point 
for the identification of markers that can be monitored to assess the health status of fish in 
a variety of environments, whether wild or bred. Due to the economic importance of and 
other fish, such endeavors may ultimately have a significant economic impact via the 
extensive efforts of federal and state wildlife management agencies. The metabolite class-
specific findings identified here will provide the impetus for additional, targeted analyses 
of response to inappetence in Atlantic salmon, as well as justify the metabolomic 
investigation of other stresses that salmonids may experience over their lifespan. 
 
Untargeted metabolomics techniques have been widely used to identify high-level 
differences between organismal or cellular cohorts, resulting in data and conclusions of the 
sort presented in this thesis.  Such information can be directly actionable in the case of 
biomarker identification (particularly in a medical context)36; however, understanding the 
mechanistic underpinnings of these high-level differences requires delving into analysis of 
individual pathways37.  In order for this information to in turn be applied at an engineering 
level, mathematical modeling is necessary, and the accuracy of such models can be greatly 




In this study of comparative metabolomics in Atlantic salmon, we identified metabolites 
that were accumulated in the inappetent cohort compared to the fed cohort.  These results 
are tentatively suggestive of possibilities for the underlying biochemistry, but cannot 
provide definitive mechanistic information.  Instead, they indicate areas of metabolism 
where deeper study and modeling may later yield key insights into Atlantic salmon 
metabolism, which efforts would be substantially aided by wider knowledge of metabolic 
regulation. 
 
2.4 Materials and methods 
2.4.1 Fish and experimental conditions 
The control group was a set of 20 post-spawning adult female domestic S. salar housed at 
the White River National Fish Hatchery (Bethel, VT). These fish spent all 4-5 years at the 
hatchery, and were feeding spawn in October/November of 2010. The fish were fed a 
maintenance diet of 1.5% body weight one time daily with Corey AquaBrood (Fredericton, 
New Brunswick, Canada). Blood samples were collected post-spawn in December of 2010. 
 
The inappetent group consisted of 20 feral sea run female S. salar that returned to the U.S. 
Fish and Wildlife Service (USFWS) Richard Cronin National Salmon Station (Sunderland, 
MA) in May of 2010. These fish originated at the USFWS White River National Fish 
Hatchery but were released as either non-feeding fry or one-year smolts into the 
Connecticut River. At age 5, the fish returned to the Connecticut River during the spring 
(April/May) to spawn but were captured at the Holyoke Dam fish lift (Holyoke, MA) and 
transported to the Richard Cronin National Salmon Station. The fish were maintained at 
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that facility in non-feeding status until they spawned in November of 2010. These fish stop 
active feeding at the onset of their spawning migrations and do not feed throughout the 
entire holding period at the Richard Cronin facility (approximately 5-6 months). Blood 
samples were collected post-spawn in December of 2010, the day after the control group 
samples were taken. 
 
Sampling of fish began at 7:30 AM for each group of fish; the control fish had last been 
fed at 4:00 PM the night before. The average size of sampled fish were 78.3 cm and and 
was similar between the two groups. The sea-run fish available for sampling were to be 
reconditioned for feeding and subsequent breeding after this study. Since the hatchery 
typically has enough sperm available for fertilization, only female kelt are maintained, and 
so the sea-run fish available for sampling were all female. Accordingly, the domesticated 
(control) fish selected for sampling were exclusively female to remove any possible gender 
effects from the study. 
 
2.4.2 Sampling procedure and sample preparation 
Blood was drawn from each fish from its hemal arch using heparinized syringes and stored 
on ice for one hour. A Pasteur pipette was inserted into the tube to ring the pre-formed clot 
and allow the red blood cells to collect at the bottom of the tube overnight at 4 ºC; the 
resulting serum was then transferred to new tubes, and stored at -80 ºC until metabolomics 
analysis. Aliquots of 50 µL of each of these samples were then further processed for mass 
spectrometry analysis by first using 150 µL of ice-cold acetonitrile to precipitate any 
protein that may have remained. The sample was then centrifuged at 21,100 xg for 7 
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minutes and the supernatant removed. The resulting serum was then evaporated to dryness 
using a CentriVap centrifugal concentrator at 40ºC and derivatized following the protocol 
laid out by Kind, et. al.38 Briefly, the samples were resuspended in 10 µL of 40 mg/mL O-
methylhydroxylamine hydrochloride in pyridine and shaken at 1400 rpm for 90 minutes at 
30ºC. Then, 90 µL of N-methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA) + 1% 
trimethylchlorosilane (TMCS) (Thermo Scientific, Lafayette, CO) was added to the 
samples, which were then shaken at 1400 rpm for 30 minutes at 37 °C. Samples were 
centrifuged at 21,100 xg for 3 minutes, and 50 µL of the supernatant was added to an 
autosampler vial. Samples were spiked with 0.25 µL of a retention time standard solution 
consisting of fatty acid methyl esters (FAMEs) and an internal standard of nonadecanoic 
acid methyl ester dissolved in dimethylformamide . 
 
2.4.3 GCxGC-MS analysis 
A LECO Pegasus 4D instrument with an Agilent 7890A gas chromatograph and 7683B 
autosampler was used to analyze the samples. Complete method details can be found in 
Appendix A. Briefly, 1 µL sample volume was injected into the inlet in splitless mode at 
250 °C. A constant flowrate of helium was kept at 1 mL/min. The oven temperature 
program started at 50 °C and ramped to 295 °C over 28 minutes, with the secondary oven 
kept at an offset of 15 °C and the modulator temperature offset kept at 35°C from the main 
oven. The first column was an HP-5 30m x 0.320 mmID x 0.25 µm (Agilent, Santa Clara, 
CA) and the second was Rtx-200 2m x 0.180 mmID x 0.20 µm (Restek, Bellefonte, PA). 
Each experimental sample was analyzed with technical duplicate injections, with sample 
order randomized to limit batch effects. A pooled quality control sample was created from 
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a small aliquot of each sample. This pooled quality control sample was prepared in the 
same way as the two sets of experimental samples, and was injected after every three to six 
samples to facilitate later data correction.  
 
2.4.4 Data Analysis 
Sample runs were first analyzed in the instrument manufacturer’s software, ChromaTOF 
(LECO, St. Joseph, MI), to determine baseline, peak area, and peak identification. Briefly, 
the following parameters were used: a baseline offset of 0.5, automatic smoothing, first 
dimension peak width of 24 seconds, second dimension peak width of 0.25 seconds, and a 
match of 700 required to combine peaks with a minimum S/N of 10 for all subpeaks. Peaks 
were required to have a signal to noise ratio (S/N) of 100 and have a minimum mass 
spectral similarity score of 800 (out of 1000) before assigning a name (both of these 
parameter choices are rather conservative). Unique mass was used for area and height 
calculation. To align the samples, MetPP39 (http://metaopen.sourceforge.net/metpp.html) 
was used with all default parameters. 
 
Peaks were filtered based on reproducibility in the quality control samples, as previously 
described40. Only peaks with less than 50% missing values and less than 50% coefficient 
of variation in the quality control samples were deemed reproducible and retained for 
further analysis. An initial missing value imputation step was then performed based on 
injection replicates; if both replicates were missing a value for a given metabolite, they 
were replaced by a small value based on the smallest measured peak. If one replicate had 




Finally, MetaboAnalyst (http://metaboanalyst.ca/) was used for statistical analysis41. The 
data matrix was log transformed and autoscaled before analysis, with variable filtering 
based on interquartile range and k-nearest neighbors (KNN) imputation of missing values. 
Analysis methods used include t-tests with false discovery rate correction (FDR) for 
multiple hypothesis testing18, principal components analysis as an unsupervised method 
for determining the axes of variation in the serum metabolite levels, and partial least 
squares discriminant analysis (PLS-DA) for supervised analysis, specifically targeting the 
combinations of metabolite levels that best separate the fed from the fasted animals. For 
enrichment analysis, metabolite pathway enrichment analysis (MPEA) was used. The data 
set was uploaded as discrete data with compound names. Metabolites were matched to their 
HMDB codes before processing the data. Data processing followed the same steps as listed 
above for missing value imputation and data normalization. The Danio rerio (zebrafish) 
pathway library was used for analysis and an in-house metabolite reference library based 
on detectable metabolites for the instrument used in this study was uploaded. Global test 
was used for pathway enrichment analysis, with relative-betweeness centrality as the 
pathway topology analysis. Pathways with an FDR < 0.05 were considered significantly 
enriched. Based on the lack of availability of a pathway library specifically for the species 
under study, analysis and interpretation of pathway-level results was generally limited and 
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Chapter 3: An in vitro reaction assay pipeline provides a 
framework for validation of putative regulatory interactions 
and a necessary increase in sensitivity range for de novo 
interaction discovery 
 
The majority of this chapter is taken from “A Gas Chromatography/Mass Spectrometry-
based enzyme activity assay pipeline for discovery and validation of putative regulatory 
interactions,” which has been submitted to Biotechniques. 
 
3.1 Introduction 
In the push toward more accurate and high-power mathematical models of metabolism, 
there is an increasingly evident need for the characterization of reversible regulatory 
interaction between metabolites and proteins; while technologies for collecting genomic, 
transcriptomic (and to a lesser extent, proteomic) data are mature and routine, regulatory 
data lags behind due to the transient, often weakly-binding nature of these interactions1.  
Ongoing efforts to systematize discovery and characterization of protein-metabolite 
regulatory interactions have resulted in many iterations on assays to detect protein-
metabolite binding, including pull-down assays2,3, dialysis partitioning4, affinity-selection 
mass spectrometry5,6, desorption electrospray ionization mass spectrometry7, and various 
computational methods for predicting such interactions8-11.  As these methods provide only 
binding pairs (or putative binding pairs, in the case of computational methods), all of these 
methods share the downstream requirement to validate and characterize the regulatory 
function of the (putative) binders via enzyme activity assays.  While this step is rarely 
focused on in regulator discovery methods, it can actually be quite complex due to protein 
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diversity and varying considerations based on how the proteins are to be expressed (and 
usually purified) for use in the assays.   
 
Enzymatic activity screening has previously been carried out through a number of mass 
spectrometry-based assays12, which represents an improvement in generalizability (and 
thus, efficiency) over individualized, enzyme-specific13 assays.  The increasing emphasis 
on developing methods for discovery and prediction of binding interactions indicates a 
growing need for an efficient, flexible framework for activity-based screens.  The 
specialized assays with product-specific reporters classically used for intensive study of an 
individual enzyme are not practical for screening beyond one or two enzymes.  Mass 
spectrometry provides a generalized platform for analysis of these reactivity screens, with 
analytical techniques utilizing various types of mass spectrometry often (though not 
always) coupled to chromatographic separation.  MALDI-MS14-16 and ESI-MS17-20 have 
both been previously used for inhibitor screening; these methods have the advantage of 
throughput and minimal sample alteration before analysis.  Adding a chromatography step 
(most often liquid chromatography) to the analysis adds to the time needed to analyze each 
sample, but in exchange allows more complex mixtures to be accurately analyzed.   
 
Interestingly, gas chromatography-mass spectrometry (GC-MS) has not often to our 
knowledge been used for such assays, even though it offers excellent chromatographic 
separation and “hard” (electron bombardment) ionization, which allows some otherwise-
difficult conversions (e.g. various isomerizations) to be distinguished more readily than 
with other mass spectrometry methods.  GC-MS also typically provides a higher level of 
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sensitivity per instrument expense than LC-MS, making it an accessible platform for many 
labs.  We believe that this, in combination with its other analytical advantages, makes GC-
MS an appropriate and particularly attractive platform for systematic analysis of enzymatic 
activity, despite requiring a more complex sample work-up procedure than various other 
methods.   
 
In addition to validation and characterization of previously-predicted regulators, such 
versatile approaches to screen for regulatory activity may also be used for de novo regulator 
discovery, by testing not just putative regulators, but a wide swathe of potential regulators.  
This is important because current in vitro screening for protein-metabolite binding 
interaction is hampered as a discovery method by the sensitivity limits of these methods; 
where limits of detection have been reported or estimated in previous studies, they typically 
land in the tens of micromolar range for the dissociation constant3,21.  As known allosteric 
interactions range into KDs as high as millimolar-scale, other methods must be employed 
to reliably screen for weaker-binding regulators.   
 
In this work, we developed a medium-throughput, GC-MS-based in vitro assay pipeline to 
be used both for rapid validation of observed or predicted binding interactions, and for the 
potential direct discovery of new regulatory pairs in a manner that bypasses the difficulty 
of conducting binding assays with weak-affinity partners.  Protein expression is discussed, 
as recommendations for how this should be done tend to vary widely (in both content and 
level of strictness) between labs.  As it is common practice for proteins under in vitro study 
(particularly with regard to screening for binding interactions) to be expressed with 
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attached affinity tags which may be used for purification, immobilization, and detection, 
we discuss three possible formats for the reaction assay step and demonstrate that the most 
appropriate format can differ by protein, which should be taken into account in systematic 
studies.  Finally, we present a proof-of-concept for a suggested iterative library screening 
via reaction assays.  These recommendations as well as the overall scheme may easily be 
generalized to use with other organisms and expression systems. 
 
 
3.2 Results and Discussion 
3.2.1 Protein expression conditions 
As it is impossible in most cases to purchase purified metabolic enzymes for a systems-
scale study and what few might be commercially available are expensive, most studies of 
multiple enzymes must begin with in-house expression.  Protein expression 
recommendations typically provide ranges of values for induction, including induction 
time and optical densities at 600 nm (OD600) at which to induce, yet efficiency of 
expression (both per unit time and unit mass) become important as experiments are 
multiplexed.  We investigated a range of induction densities spanning a typical mid-log 
recommendation (OD600 0.7-1.2), as well as near saturation (OD600 ~3.5), and periods of 4, 
9, and 16 hours.  
 
Three S. cerevisiae enzymes of diverse chemistry were chosen for the purposes of pipeline 
development – chorismate mutase (ARO7), cytosine deaminase (FCY1), and aspartate 








ARO7 Chorismate mutase chorismate  prephenate 
FCY1 Cytosine deaminase cytosine + water  uracil + ammonia 
AAT2 Aspartate 
aminotransferase 
L-aspartate + 2-oxoglutarate = 
oxaloacetate + L-glutamate 
 
 
As seen in Figure 3.1, the expression patterns differ for the various proteins.  Longer 
induction periods typically produced significantly more protein per mass than shorter ones, 
whereas induction density was generally less important over the range surveyed.  The 
differences between proteins suggest that some degree of optimization for each different 
protein to be studied could provide modest improvements, but for most practical purposes 
this is not necessary. 
 
 
Figure 3.1: Relative quantification of expression of three enzymes under different expression protocols. 
Protein expression is most efficient when induction is carried out during log-phase growth, but precise 
induction density is minimally important.  Values calculated per wet cell pellet mass; error bars represent the 




While inducing at very high cell density is hardly optimal in terms of expression efficiency 
per cell mass and time, with an overnight induction period, the disadvantages of doing so 
are reasonably ameliorated by the logistical advantages, as growth timing can sometimes 
be a tricky proposition on a practical/logistical level. Of note, we show that “overgrown” 
cultures may still be induced to express an acceptable amount of the target protein with 
likely greater convenience. 
 
3.2.2 Reaction assay architecture 
In most research documentation dealing with regulator discovery, the reaction assay itself 
is frequently trivialized because it has previously been developed or is commercially 
available, but the in-lab reality is often one of tedious troubleshooting of individual 
proteins, which can drastically reduce the efficiency of the research and is directly 
counterproductive to attempts to systematize these discovery efforts.  For broad studies of 
many enzymes, a middle ground is needed between intensive focus on individual enzymes 
and a single, “catch-all” method that may not in reality behave acceptably for many 
proteins.  We therefore sought to establish a reaction assay format framework that can be 
varied according to specific needs of the research to be conducted as well as the respective 
sensitivities of the proteins involved, while still maintaining some degree of 
standardization: in some cases it may be reasonable to sacrifice protein purity or baseline 
activity for speed, while in others, it may be desirable or necessary to conduct reaction 
assays as soon after lysis as possible.  In others still, large affinity tags on the proteins may 
interfere with folding or ligand binding, and thus require cleavage in order for the enzyme 
to become active.  (When using expression systems other than the MORF library, which 
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includes a C-terminal ZZ-tag of ~17 kDa, any large affinity tag will pose the same potential 
issues.) 
 
The three proteins used in this work reflect the diversity of requirements and permissible 
environments for protein function. ARO7 was robust; it retained activity following 
multiple different purification methods, allowed easy detection of activity even from crude 
lysates, and remained stable at 4 °C for several days.  AAT2 was also robust in terms of 
activity, but the lysate matrix made measurement of activity unduly difficult in a lysate-
based assay.  FCY1, by contrast, was active in lysate, but lost all activity by the time it was 
purified and dialyzed.  We identified that this loss in activity was due to FCY1’s relative 
lack of stability in solution once extracted from the cell; within a few hours with or without 
dialysis, FCY1 lost almost all activity.   
 
To address the limitations in FCY1’s stability in anticipation of similar problems with other 
enzymes, we developed and validated an “on-bead” assay for enzyme activity wherein the 
reaction is carried out while the enzyme is still non-covalently attached to an affinity-based 
purification medium.  This assay format allows a compromise between speed and protein 
purity; while more logistically involved than a lysate assay, it lacks the lengthy downstream 
steps of dialysis out of an elution buffer and/or cleavage of an affinity tag, providing 
essentially pure enzyme without a long incubation.  It would be inappropriate for enzymes 
that require the removal of an attached affinity tag to avoid steric hindrances of function, 
and the agarose matrix may itself slow activity in some cases due to steric hindrance.  
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Nonetheless, for cases where a protein has poor stability and catalyzes a fast reaction but 
where a lysate assay is undesirable due to matrix issues, it is an appropriate choice. 
 
Comparative results for all three test-case proteins are summarized in Table 3.2.  ARO7 
demonstrates the highest relative conversion in an on-bead assay.  For FCY1, conversion 
is complete in both the lysate and on-bead conditions, but the on-bead assays showed high 
variability and much lower overall uracil abundances than the lysate condition, likely due 
to incomplete removal of the reaction mixture from the agarose bead matrix.  No-substrate 
control samples of FCY1 lysate show a significant amount of natively-present uracil, but 
those amounts are orders of magnitude lower than in the substrate-added condition, 
rendering a lysate assay a reasonable and convenient option for that protein.  Finally, 
AAT2’s relatively complex lysate background (substantial native quantities of both 
glutamate and aspartate) and bi-molecular chemistry make the fully-purified structure 
decidedly preferable.  
 
Table 3.2: Summary of enzyme behavior over differing reaction assay architecture, illustrating 
differences across enzymes 
Protein Lysate On-bead Fully purified 
ARO7 Clear activity with no 
appreciable 
background 
2x more conversion/time 
relative to lysate 
Low but detectable 
activity 
FCY1 Fast, complete 
conversion with 
simple background 
Complete conversion but 
inconsistent detection 
Minimal activity 
AAT2 Activity but with 
complex, obfuscating 
background 
No activity detected Activity comparable 






Given these observations, we suggest the following for methodology selection: 
1. Full purification is the default preferred option, given that it offers the fewest 
complications that may impede the protein’s unregulated activity or make data 
analysis difficult.  If the ZZ-tag interferes with protein folding, full purification 
and cleavage are strictly necessary, and ongoing reactions other than the one of 
interest can present an interpretation problem in lysate. 
2. Lysate assays offer speed and convenience with potential sacrifice of data clarity, 
as their utility is limited to those reactions whose substrate(s) and product(s) are 
both easily detected against a cell lysate background and are not major 
participants in other post-lysis reactions.  
3. On-bead assays offer a compromise between speed and clarity, but the large tags 
that remain on the enzymes may cause some hindrance of metabolite binding 
and/or protein subunit assembly, and metabolite absorption by the agarose matrix 
may also factor into reduced reactivity and detected compounds. 
 
 
3.2.3 Screening putative regulator libraries for inhibitory/activating activity 
While there are many potential applications for enzymatic activity assays, our main 
motivation behind the study and characterizations above was to implement an efficient 
pipeline for validating predicted (via in vitro or in silico techniques) regulatory interactions, 




For regulator validation, assuming a small number of hypotheses generated either via 
observation of binding interactions in vitro2-4,22 or in silico prediction8,9 this is a simple 
matter: one putative regulator is added to one reaction mixture, and the enzyme’s activity 
in the presence of the compound is compared to its unregulated activity, subject to 
appropriate controls.  
 
Using this methodology for de novo discovery or validation screening of a larger number 
of predicted potential regulators (as may be produced by some in silico modeling) requires 
iterative screening of a library followed by smaller subsets of that library to narrow down 
potential sources of regulatory activity.  We used S. cerevisiae chorismate mutase (ARO7) 
as the test case to demonstrate this approach, as it has two well-studied23,24 allosteric 
regulators - it is inhibited by tyrosine and activated by tryptophan - that allow for positive 
controls in a hypothetical process of regulator library screening. 
 
An initial screening library of ten compounds was selected for purposes of illustration, 
including tyrosine and tryptophan.  Other compounds in the library were chosen from 
central carbon metabolism, nucleotide biosynthesis, and elsewhere in amino acid 
metabolism.  The reasoning behind these selections was that amino acid metabolism and 
nucleotide biosynthesis pathways have a high degree of overlap, and various metabolites 
in glycolysis and the tricarboxylic acid (TCA) cycle are also used as feedstocks for 
secondary metabolism pathways; altogether, the library presents a logical assortment of 




The general scheme for this library screening is to conduct reaction assays with the full 
library, then divide the library repeatedly according to activity changes observed, as 
diagrammed in Figure 3.2A.  Groups D, E, and F are representative possible sub-groupings 
from B and C for purposes of demonstration.  In an actual discovery-oriented screening 
study, B and C would simply be arbitrarily divided in half/near-half without recombination, 
but in this case we included Group D to represent a case where two as-yet unknown 
regulators were allocated to the same sub-library.  Figure 3.2B shows changes in activity 
due to library and sub-library aliquots added to the reaction mixtures.  This data clearly 
narrows down the library of “putative” regulators to tryptophan as an activator; however 
the influence of tyrosine in this data is indistinct due to low unregulated activity.  
Depending on the kinetics of a given enzyme and amounts being used, it may be desirable 
to lengthen the reaction time or shorten it – here, tyrosine inhibition of ARO7 is indistinct 
due to a likely overly-short choice of reaction time, whereas with, for instance, FCY1, an 
activator would be difficult to distinguish except over a very short timeframe, as the 
unregulated reaction goes to completion in our standard protocol.  While this adds another 
point of assay diversification/tailoring to individual enzymes, it is a minor and easily-





Figure 3.2: Iterative regulator screening demonstrated in ARO7, narrowing down from a metabolite 
library to the known regulators.  Here tryptophan shows clear activation; inhibition by tyrosine is not 
significant, indicating a longer reaction time is appropriate.  Activation in Group D demonstrates dominance 
of one allosteric regulator over another.  A) Libraries used.  Known activators and inhibitors written in green 
and red, respectively.  B) Comparative activity of ARO7 exposed to different candidate libraries.  Error bars 
represent the standard error of the mean; n=4. 
 
The initial library (Group A)’s significant activity boost over its tryptophan-including 
subdivisions was investigated and determined to be due to A’s higher acidity, which is a 
known factor in chorismate mutase activity.  As pH sensitivity of enzymes is not 
uncommon, we recommend measuring the pH of the libraries to be used and adjusting as 





In order to investigate the suitability of larger initial screening libraries, further reaction 
assays were carried out using ARO7 lysate and metabolite libraries of 15, 25, and 50 
compounds at 1 mM.  The components of these libraries were chosen based largely on 
availability, and are listed in Appendix B.  The working hypothesis for this experiment was 
that at larger library sizes, the effects of ARO7’s known regulator might be made 
indistinguishable due to matrix effects and/or competing presence of multiple other 
regulators.   
 
Substrate and product peaks were easily distinguished over all conditions, and the results 
were surprising (Figure 3.3).  Rather than cause a loss of observable regulation by tyrosine 
and tryptophan with larger libraries, use of the 25-compound and 50-compound libraries 
resulted in a dramatic decrease in chorismate mutase activity (and these conditions were 
also distinct from one another), while the results for the 15-metabolite libraries were 
statistically indistinguishable from the unregulated and tyrosine- or tryptophan-only 
conditions (though the tyrosine-only and tryptophan-only conditions were distinct from 
each other).  The obfuscation of tyrosine and tryptophan’s effects in the 15-compound 
libraries is tentatively explainable by the fact that the assays were conducted in lysate, and 
both of those amino acids participate in many other parts of metabolism.  Tyrosine, in 
particular, was only barely detectable in the samples where it had been added as part of the 
library.  The fact that the tyrosine- and tryptophan-containing versions of the 25- and 50-
compound libraries did not produce results distinct from each other indicates that the 
regulatory effects of those two metabolites were indeed being obfuscated, but likely by the 
presence of a far-stronger inhibitor of ARO7 (possibly more than one, given that the 25- 
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and 50-compound conditions were distinct from one another as well as from the other 
conditions).   
 
Figure 3.3: Extended library size comparison for ARO7 reactivity in lysate.  Numbers in parentheses are 
the number of compounds in the library added to the reaction mixture for each condition.  Every library size 
pair contains one of tyrosine or tryptophan (A, C, and E contain tyrosine as their final compound; B, D, and 
F contain tryptophan).  Error bars represent the standard error of the mean.  Asterisks indicate p-values via t-
test: *p < 0.04; **p < 0.03. 
 
Taken together, these results do not suggest the presence of a generalizable upper limit to 
initial library size.  Practical/logistical considerations seem likely to be a reasonable guide 
for initial library construction lacking other basis for decision.  However, rather than 
construct a single initial screening library containing all the endogenous metabolites 
available to hand, it may be prudent to begin instead with two or three different libraries of 
intermediate (relative to the practical maximum determined by available resources) size, if 
a very large number of compounds are available.  It of course remains a possibility with 
any given protein that competing regulators of similar strength might offset one another’s 
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effects; as with any broadly-applied search strategy for putative regulators, some false 
negatives may be expected to occur.   
 
Finally, the results summarized in Figure 3.3 indicate a clear avenue of future investigation 
regarding the apparent existence of one or more strong inhibitors of yeast chorismate 
mutase.   
 
3.2.4 GC-MS method optimization for screening individual enzymes 
Since this validation and discovery methodology is based on observed differences in 
enzymatic activity, good chromatographic resolution is only necessary around the product 
and substrate peaks.  This allows for GC methods to be tailored to a given enzyme to reduce 
the time needed for analysis of a large set of screening reactions.  For example, the substrate 
chorismate and product prephenate of chorismate mutase (ARO7) elute closely to each 
other, but do not co-elute.  Thus we created a shortened screening method for chorismate 
mutase activity by only designating a slow temperature ramp (10°C/min) during the elution 
temperature window of chorismate and prephenate, and using a faster one outside of it.  
This approach decreased sample-to-sample time by ~40% relative to typical sample runs 
in our lab, which are designed for complex matrices.  Runtime could be reduced even 








Activity-based screening is both a necessary component for validation of previously-
predicted regulatory interactions and a flexible platform to broaden the range of affinity 
strengths of regulatory interactions for which we can assay in medium-throughput.  In this 
work, we have developed a set of guidelines and considerations for adapting a general mass 
spectrometry-based activity assay to more specific needs, and an iterative scheme for 
efficient screening for de novo regulator discovery.  Our methodology provides a flexible 
schema for validating hypothesized regulators and pursuing de novo regulator discovery.  
As both a part of the ongoing screening studies for protein-metabolite binding pairs and a 
higher-sensitivity strategy orthogonal to them, we believe it can significantly speed 
regulator discovery efforts and thereby improve our understanding of metabolic regulation. 
 
 
3.4 Materials and methods 
3.4.1 Chemicals and media 
Specialty yeast media ingredients (yeast nitrogen base, Synthetic Complete-uracil dropout 
amino acid mix) were purchased from Sunrise Scientific.  Other media and buffer 
components were purchased from VWR Scientific.  Chemical reagents for the reaction 
assays were purchased from Sigma-Aldrich. 
 
3.4.2 Yeast culture and protein expression 
The Moveable-ORF yeast protein library was purchased in yeast glycerol stock format 
from OpenBiosystems.  Individual strains over-expressing ARO7, FCY1, and AAT2 
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respectively were streaked from stocks onto uracil-dropout SC-ura + 2% dextrose plates 
and incubated at 30 °C for two days.  Single colonies were inoculated into 5 mL liquid SC-
ura/2% dextrose and incubated in a rotating drum at 30 °C for 1-2 days, and the cultures 
subsequently used to make working glycerol stocks.  
 
For preparative protein expression, appropriate MORF clones were grown in 5 mL liquid 
SC-ura/2% dextrose for 1-2 days to visual turbidity.  From these cultures, 500 μL was used 
to inoculate 300 mL SC-ura/2% dextrose cultures in shake flasks, which were grown 16 
hours in a 30 °C water bath, with shaking at 170 rpm.  
 
Expression was induced at OD600 0.7-1.2 by media exchange (as the GAL promotor is 
inhibited by glucose): under sterile conditions, the 300 mL cultures were split into six 50 
mL conical tubes and centrifuged at 3000 rpm for 3.5 minutes.  The media was decanted 
from the pellets, which were then each resuspended by vortexing in 10 mL SC-ura/2% 
galactose/3% glycerol/2% ethanol expression media and recombined in their flasks, with 
media then added to 450 mL final volume.  
 
The cultures were then returned to the shaker for 10-16 hours to allow protein expression, 
and harvested into two 50 mL conical tubes by centrifugation (3500 rpm, 3 minutes).  Cell 
pellets were then either lysed immediately or stored at -80 °C.  
 
 
3.4.3 Expression assays 
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To compare expression conditions for each protein of study, pre-expression cultures were 
grown as described above in 300 mL SC-ura/dextrose media.  At OD600 0.7, 1.0, 1.2, and 
near-saturation, 5 mL samples were withdrawn and induced, at which point they were 
incubated at 30°C with rotation for either 4, 9, or 16 hours prior to harvesting by 
centrifugation for 3 minutes at 2739 xg and storage at -80 °C.  
 
The cell pellets for each protein were lysed using the method described in the section 
below, scaled down to 200 μL each lysis buffer and beads.  
 
Comparative expression was assayed via dot blot for each protein of interest.  Briefly, 2 
μL of each sample was spotted onto a nitrocellulose membrane and allowed to dry.  The 
blots were blocked for at least 1 hour on a rocker plate in 5% bovine serum albumin (BSA) 
in PBST.  The blocking solution was removed, and the blots hybridized for 1 hour on a 
rocker plate using anti-5xHis-Alexa647 (Qiagen), diluted 1:10,000 in PBST/1% BSA.  The 
blots were then washed 3 times for 5 minutes each with PBST, followed by a 1-minute 
wash in PBS, and scanned for fluorescence at 647 nm.  
 
Each individual condition was assayed in triplicate for each protein.  
 
3.4.4 Cell lysis and protein purification 
Preparative culture cell pellets (~0.8-1.2 g wet mass) were lysed in 700 μL PBST with 10 
μL no-EDTA protease inhibitor cocktail (G Biosciences) and 1.5 mL 0.5 mm soda lime 
glass beads, by vortexing (3x 5-minute cycles, with a 1-minute quick-chill at -80 °C after 
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each cycle).  The liquid was transferred to microcentrifuge tubes, and the beads washed 
twice with 700 μL of the lysis buffer (also added to the tubes).  The lysate was centrifuged 
for 3 minutes at 10,000 rpm to remove cell debris, and then either stored at -80 °C or used 
immediately.  
 
The MORF library proteins have two tags which may be used for purification25 – a large 
Protein A tag and a 6x-histidine epitope tag.  For preparative purifications, we used 
immobilized metal ion affinity chromatography (IMAC) via HisPur Co2+ resin (Thermo 
Scientific).  Crude lysates prepared as described above were diluted 1:1 with PBS + 10 mM 
imidazole, then added to 500 μL cobalt resin (pre-washed with PBS + 10 mM imidazole) 
and incubated for 20 minutes.  After 700 xg centrifugation and removal of the supernatant, 
the beads were washed 3x with 1 mL PBS + 10 mM imidazole.  Purified proteins were 
eluted with 3 washes of 500 μL PBS + 150 mM imidazole, then clarified via 0.22 μm 
cellulose acetate spin filter.  To remove the ZZ-tag (which is cleavable via a 3C protease 
cut site) and imidazole, half the pooled eluates were placed in mini-dialysis cartridges (GE 
Healthcare) with 4 µg Turbo GST-3C protease (Accelagen), mixed, and dialyzed into PBS 
overnight at 4 °C.  The unused half was saved for diagnostic analysis if necessary.  The 
next day, the protease was removed by 30-minute incubation with 20 μL glutathione-
agarose resin (Thermo Scientific).  The protein samples were then filtered at 0.22 μm 
before use.   
 
3.4.5 Reaction assays 
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Reaction assays were set up to assess relative enzyme activity as follows: 10 μL of each 
substrate solution (10 mM in water) was added to a protein sample (in the form of crude 
lysate, bead-bound, and fully purified and tag-cleaved protein dialyzed into PBS – volumes 
20 μL, 40 μL, and 15 μL respectively such that each sample would be the same fraction of 
the overall volume at that stage) in a microcentrifuge tube, and incubated for one hour at 
30 °C.  
 
In the bead-bound condition, 40 μL of 1:1 diluted lysate was added to 20 μL cobalt resin 
and incubated on a rocker for 30 minutes.  The samples were centrifuged for 1 minute at 
700g and the supernatant removed, with two subsequent washes of 60 μL PBS/10 mM 
imidazole, followed by one wash of only PBS.  The beads were resuspended in 10 μL PBS, 
with the substrate added and incubated as above.  To separate the reaction mixture and the 
beads, the reactions were transferred to a 0.22 μm cellulose acetate spin filter, and the 
clarified reaction sample removed for GC-MS analysis.  
 
Reaction assays for library screens were carried out using 10 μL ARO7 protein sample (in 
purified or lysate form), 10 μL chorismate (10 or 20 mM in water), and 10 μL metabolite 
library or single known regulator (all constituents at 1 mM in PBS) or PBS alone, mixed 
together in a microcentrifuge tube and incubated for 1 hour at 30 °C. 
 
3.4.6 Deproteinization and GC-MS sample preparation 
The reaction assay samples were prepared for GC-MS analysis by acetonitrile extraction 
and trimethylsilyl derivatization.  Briefly, 3 sample volumes of ice-cold acetonitrile were 
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added to the samples, which were then mixed by vortexing and centrifuged at 20,000 xg 
for 3.5 minutes.  The supernatant was pipetted off any solid material and transferred to 
clean tubes, then dried completely at 40 °C under vacuum in a Labconco CentriVap.  
 
The dried samples were derivatized per the procedures of Fiehn, et al26 (90 minutes in 10 
μL 40 mg/mL methoxyamine in pyridine, with agitation, at 30°, followed by addition of 
90 μL MSTFA + 1%TMCS (Thermo Scientific) and further incubation for 30 minutes at 
37° with agitation) prior to GC-MS analysis.  
 
3.4.7 GC-MS 
All samples were analyzed on an Agilent 7890B gas chromatograph with 5977A 
quadrupole MSD, using 1 μL splitless injection onto a HP-5MS (phenyl methyl silox) 
column, with a temperature ramp from 45°C to 310°C. 
 
3.4.8 Reaction assay data analysis 
Peak deconvolution and integration was performed in AMDIS 2.7127, with subsequent 
alignment using SpectConnect28, both with default parameters.  Protein activity was 
assessed by calculating the ratio of a characteristic product peak to a characteristic substrate 
peak.  For lysate-based samples, additional samples of lysate with no substrate were 
prepared, to account for any detectable amount of substrates and products already present 
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Chapter 4: Small-molecule microarrays (SMMs) present a 
potential platform for high-throughput binding interaction 
discovery, albeit with unique challenges 
 
4.1 Introduction 
In order to construct systems-level mathematical models of metabolism, broad-scale 
characterization of regulatory interactions is necessary.  As discussed previously, high-
throughput discovery strategies for protein-metabolite interactions have not yet been 
effectively implemented - time and labor requirements for regulatory interaction discovery 
and characterization have remained high compared to other areas of investigation for which 
the analytical technology is mature. 
 
Microarrays are a massively-parallel platform for probing binding interactions, with a 
genesis in probing for gene expression levels1,2. While the microarray principle has since 
been applied to proteins3, RNA4, and small molecules5-7 in addition to DNA oligos, the 
basic concept remains the same: solutions of molecules to be tested are printed in micron-
scale spots with a known configuration on glass slides. The slides may be functionalized 
in some manner, which may be covalent or noncovalent6, to improve the binding behavior 
of the printed molecules. A prepared array may then be probed with a solution of the 
putative binding partner(s). Binding detection is typically accomplished by fluorophore 
labeling. 
 
Scalability is the primary incentive for microarray analysis; microarrays of all types share 
the advantage of extremely low resource use per interaction probed. Whereas an in vitro 
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binding assay requires amounts of solution on the order of one milliliter per sample, an 
entire batch of microarrays requires only microliter amounts. Furthermore, in the case of 
SMMs, the protein needed to probe a single array is < 10 μg, as opposed to much higher 
amounts (on the order of hundreds of micrograms) used in a milliliter-scale in vitro 
experiment, or the milligram amounts needed for some previously-developed assays8. 
Arrays on a glass substrate also present the advantage of comparatively low nonspecific 
binding tendency for hybridization materials versus porous blotting substrates1. 
 
In the context of protein-metabolite interaction discovery, SMMs provide the capability to 
test a given protein against hundreds of metabolites simultaneously, with all steps of the 
procedure including the final scan and data analysis conducted in parallel.  If successfully 
implemented, this would therefore provide an orders-of-magnitude scale increase of assays 
per time over mass spectrometry-based methods. 
 
Small-molecule microarrays as used in this research make use of reactive isocyanate-
functionalized glass slides. Isocyanate reacts with most functional groups in biological 
molecules (e.g. thiols, alcohols, amines, indoles, carboxylic acids, phenols6), resulting in 
covalent attachment of the metabolites to the glass substrate. A flexible polyethylene glycol 
linker sits between the isocyanate and the glass, allowing for increased conformational 
freedom for the printed metabolites (Figure 4.1). Once prepared, the arrays are probed with 
protein displaying a histidine affinity tag, and a secondary hybridization with fluorophore-




Figure 4.1: Metabolite attachment chemistry.  A flexible PEG linker and reactive isocyanate group are 
attached to amine-functionalized glass slides.  The metabolites are then printed onto the slides, where certain 
functional groups can react with the isocyanate moiety to form covalent bond.  Figure adapted from Bradner, 
et al, 2006.6 
 
 
Figure 4.2: Simplified diagram of a double-hybridized SMM.  The protein binds to the printed molecule 
in the primary hybridization.  The secondary hybridization step attaches a fluorescently-labeled antibody to 
the 6xHis tag, allowing detection of the bound protein. 
 
This SMM methodology was originally developed with high-throughput screening of 
compounds for drug discovery in mind.  We sought to adapt this method to create a 
Saccharomyces cerevisiae “endogenous metabolome microarray” to screen for 
endogenous protein-metabolite interactions.  This chapter will discuss early protocol 
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optimization efforts using high-affinity positive protein-metabolite pairs and explore the 
additional challenges posed by applying SMMs to endogenous interaction discovery.   
 
4.2 Results and Discussion 
4.2.1 Initial validation and optimization of basic protocol 
As the construction and hybridization of SMMs is a complex procedure with several major 
points of failure, we carried out sequential validation of the following: array synthesis and 
covalent printing, primary hybridization, secondary hybridization.   
 
Array synthesis with subsequent covalent attachment of a small molecule was validated by 
printing the fluorescent dye rhodamine B onto an active array and scanning for 
fluorescence after downstream workup.  Primary hybridization was demonstrated on the 
streptavidin-biotin binding interaction by printing biotin and hybridizing with fluor-labeled 
streptavidin.  Secondary hybridization was initially demonstrated using 6x-histidine-
tagged streptavidin and fluorophore-labeled anti-5xHis antibody, and further shown in the 
same manner with the weaker-binding pairs FKBP12-rapamycin and FKBP12-FK506.  We 
were thus able to replicate detection of positive control interactions suggested in the 




Figure 4.3: Progressive validation of basic arraying and hybridization protocols.  A. Rhodamine B 
(green) and primary hybridization of fluor-tagged streptavidin to printed biotin (red).  B. First successful 
secondary hybridization; 6xHis-tagged streptavidin bound to printed biotin, with detection via secondary 
hybridization using anti-5xHis-Alexa647.  C. Rhodamine B (green) and clean primary-secondary 
hybridization of 6xHis-FKBP12 bound to printed rapamycin and detected via anti-5xHis-Alexa647 (red). 
 
Print quality (namely, metabolite spot size and consistency) was an issue encountered and 
explored at various points throughout the SMM work (Figure 4.4).  The specific needs of 
a lab making use of SMMs will vary with instrumentation; however, it is worth noting on 
a general level that spot quality was heavily dependent on the following factors: 
 
1. Solvent used for the metabolite to be printed.  This is a particularly relevant 
concern for a broad-spectrum application to endogenous metabolites, as their 
solubility profiles vary widely.  With our instrument and pins, water produced the 
smallest and most regular spots, followed by dimethyl sulfoxide (DMSO), 
followed by dimethylformamide (DMF).  Neither ethanol nor 50:50 ethanol/water 
could be printed at an acceptable spot density.   
2. Microarraying pin design.  All work presented here was completed using 
channeled silicon wafer microarraying pins; a different, “partially-etched 
channel” pin model from the same manufacturer resulted in smaller spot size 
(which, on a practical level, increases flexibility in solvents and printing density).   
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3. Microarraying pin condition and cleanliness.  Most microarray printers are 
equipped with a wash station, but designing a protocol appropriate to the pins and 
solutions being used is still nontrivial.  We found it necessary to remove from the 
printhead and manually inspect the pins (using a microscope) on a regular basis to 
ensure that they remained in good condition and spot quality, consistent.   
 
 
Figure 4.4: Spot morphology comparison, showing FKBP12 bound to printed rapamycin.  A. Variation 
of spot morphology within a single print run.  Each cluster of twelve spots was made by one pin; solvent was 
DMSO.  A pin being slightly dirty or damaged results in the spots running together during printing.  B. 
Rapamycin printed in 50/50 DMSO/water and spotted with partially-etched channel pins. 
 
Unsurprisingly, specific details of the hybridization and wash procedures had a strong 
impact on the quality of the final array scan.  Gentle agitation on a rocker plate during all 
incubation steps was preferable to the protein-conserving “Parafilm method” for primary 
hybridization (which involved pipetting a ten-fold smaller volume than used for a dish 
incubation onto a piece of Parafilm and placing the array face-down on the droplet such 
that it covered the array surface), but the latter gave detectable spots even if high or 
inconsistent background.  However, the weaker the binding pair to be detected, the higher 
the hybridization quality generally required; such a higher-background method is therefore 
unlikely to be suitable in screens for endogenous protein-metabolite interactions, as these 
affinities may be many orders of magnitude weaker than the positive control cases 
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presented.  (In the original target application of the SMM methodology adopted for this 
work, which was a chemical biology search for drug candidates, detecting low-affinity 
interactions was generally undesirable anway, allowing a higher tolerance in parts of the 
protocol that affect final array quality.) 
 
4.2.2 Sensitivity limitations 
In the originally-published protocol, the reported detectability limit is a dissociation 
constant of 50 μM5.  Many, perhaps the majority, of known allosteric interactions are near 
(within an order of magnitude) that limit, or even higher.  As previously discussed, S. 
cerevisiae chorismate mutase (ARO7) presented a useful positive control for endogenous 
interaction detection, as its two known regulators, tyrosine and tryptophan, have affinities 
of 50 μM and 1.5 μM, respectively.   
 
4.2.3 Photocrosslinking strategy for increasing primary hybridization sensitivity 
Repeated lack of success in detecting either of these interactions on an array in addition to 
our understanding of other allosteric interaction affinities led us to pursue a means of 
improving the sensitivity of the assay. Our hypothesis was that the bound metabolite was 
being washed off of its binding partner during the subsequent antibody hybridization and 
multiple washes, such that the protein must remain bound through those steps in order for 
the interaction to be detected.  If dissociation of a protein-metabolite binding pair could be 
prevented after the initial capture, there would be potential for dramatic improvement in 
the assay’s practical limit of detection, albeit at the likely cost of an increased frequency of 




We therefore explored the use of a photo-inducible crosslinker as a means of “fixing” the 
primary hybridization in place prior to proceeding with the antibody hybridization.  
Succinimidyl 6-(4,4'-azipentanamido)hexanoate (NHS-LC-Diazirine, or LC-SDA; Figure 
4.5) is a heterobifunctional crosslinker with an amine-reactive moiety (NHS ester) and a 
nonspecifically-reactive, UV-inducible moiety (diazirine), which are connected by a spacer 
arm.  The NHS ester hydrolyzes readily in solution, leaving behind a carboxyl group that 
is compatible with the isocyanate attachment chemistry in SMM production, allowing it to 
be mixed into the metabolite solutions to be printed and resulting in mixed metabolite-
crosslinker spots.  After primary hybridization of the array, exposure to UV light prior to 
removing the primary hybridization solution activates the diazirine moiety, forming a 
carbene intermediate which then reacts nonspecifically with an amino acid side-chain or 
peptide backbone of the nearby protein.  This fixes nearby protein covalently to the spot, 
which prevents that protein from being washed off in subsequent hybridization and wash 
steps in the array workup.   
 
 




We conducted initial validation of this concept’s chemistry by crosslinking rhodamine B 
dye or green fluorescent protein (GFP) to IgG-agarose beads, and by printing LC-SDA 
crosslinker only (not mixed with a metabolite) onto arrays at various concentrations 
followed by a typical two-hybridization array workup with an arbitrary tagged protein 
(FKBP12-6xHis).  The crosslinker behaved as expected in the IgG bead/fluorophore 
crosslinking tests.  When printed onto a microarray at a concentration of 1 mM, a detectable 
amount of protein was nonspecifically captured during the UV exposure, indicating that 
this capture scheme can work on an array (Figure 4.6).  At LC-SDA print concentration of 
0.1 mM or less, nonspecific capture was not detectable, indicating that mixing small 
amounts of it with metabolites to be printed should mitigate the increase in false positives.  
(For comparison, FKBP12-rapamycin was easily detected when rapamycin was printed at 
a concentration of 2 μM.)   
 
 
Figure 4.6: Detectable non-specific capture of FKBP12 with 1 mM printed LC-SDA crosslinker when 
treated with UV (boxed slide segments on bottom row).  The top row of each slide was printed with 




Attempts to demonstrate the intended sensitivity increase, however, were unsuccessful, 
albeit due to the lack of an appropriate test case.  The interaction between FKBP12 and 
rapamycin is strong (KD = 0.5 nM) enough that there was no appreciable attenuation of 
signal with increasing length and number of post-hybridization washes.  Incubation with a 
solution of 8 M urea + 100 mM beta-mercaptoethanol resulted in an overall reduction of 
signal, but did not succeed in completely stripping slides of bound FKBP12 with or without 
crosslinking; we therefore concluded that any sensitivity advantage conferred by the 
crosslinking step would not be observable using FKBP12-rapamycin.  Attempts to apply 
the method to ARO7 still did not allow detection of its known interactions. 
 
4.2.4 Destruction of binding functionality in small printed metabolites 
Repeated validation of ARO7’s correct folding and functionality (see Chapter 3) via 
reaction assay led to the hypothesis that the attachment of its regulators to a microarray 
destroyed the moieties required for proper binding to the protein.  Tyrosine and tryptophan 
(181.2 g/mol and 204.2 g/mol, respectively) are quite small in comparison to rapamycin 
(914.2 g/mol), and have fewer functional groups available to react with the isocyanate to 
form a bond to the array, resulting in a higher likelihood that their ability to bind to ARO7 
may be destroyed by array attachment.   
 
Evidence supporting this hypothesis was gathered by conducting a reaction/regulation 
assay of ARO7 with tyrosine, tryptophan, N-acetyl-tyrosine, and N-acetyl-tryptophan.  
Unsubstituted tyrosine and tryptophan demonstrated the expected regulatory behavior, 
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while the N-acetylated amino acids did not, indicating a strong likelihood that ARO7’s 




Given general knowledge of structural trends for metabolites in central carbon and amino 
acid metabolism (small) and binding affinity trends for known interactions (weak), the 
results described above indicate that SMMs may not be appropriate tools for screening for 
binding interactions of small metabolites if they are uniformly attached to the substrate via 
a moiety that is likely to be involved in protein binding.  While some false negatives are 
acceptable and expected in such an assay, since the small endogenous metabolites we are 
interested in studying have few potential array linkage points for a moiety-specific 
attachment chemistry (even one with multiple potential attachment moieties such as the 
isocyanate chemistry) , the false negative rate will be increased to a level we expect to be 
impractical.  Photocrosslinking, however, may still provide a reasonable avenue for 
increasing the assay’s sensitivity: attaching metabolites in a non-specific manner to the 
array in a way that allows for some fraction of the attachments to be non-destructive to 
their native binding interactions could circumvent these issues.  
 
4.4 Materials and Methods 
4.4.1 Small-molecule microarray synthesis 
SMMs were synthesized following the protocol described by Bradner, et al.5  Briefly, 
amino-functionalized glass slides (Corning GAPS II) were completely submerged in a PEG 
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solution (1 mM fmoc-8-amino-3,6-dioxaoctanoic acid, 2 mM PyBOP, 0.5 mM DIPEA in 
DMF) and incubated at room temperature with stirring overnight (or at least 4 hours).  The 
slides were briefly rinsed with DMF, then submerged in 1% vol/vol piperidine in DMF for 
10 minutes, before being washed in DMF for 1 minute with stirring, then submerged in 1% 
1,6-diisocyanatohexane in DMF with stirring for 30 minutes to install the reactive 
isocyanate group.   
 
The slides were then washed twice with DMF, 3 minutes with stirring, then a third time 
with THF for 2 minutes before being allowed to fully air dry and transferred to the print 
bed of a Genetix QArray2 microarray printer equipped with a Parallel Synthesis silicon 
wafer print head and silicon wafer arraying pins.  Metabolite solutions were printed at 
various concentrations in water, DMSO, or DMF and the spots allowed to completely air 
dry.  Rhodamine B was additionally printed as a positional reference point and an indicator 
that the array synthesis was successful.  The printed slides were placed in a vacuum 
desiccator chamber and exposed to pyridine vapor overnight.   
 
The next day, the slides were removed from the chamber and immersed in 5% ethylene 
glycol and 0.1% pyridine in DMF for 30 minutes with stirring, followed by a rinse in DMF 
and a 1 hour, stirred wash in DMF and two subsequent 3 minute washes in THF.  They 
were allowed to air dry, then either used immediately or packaged into five-slide boxes 
sealed with Parafilm and stored at -20 °C in a secondary container with desiccant for future 




4.4.2 Array hybridization and analysis 
6xHis-tagged proteins of interest were diluted to a concentration of 0.1-5.0 μg/mL in 
phosphate-buffered saline plus 0.1% Tween 20 (PBST) at 4 °C.  Microarrays were covered 
in protein solution and incubated for 1 hour on a rocking platform.  The protein solution 
was then removed and the slides briefly rinsed in chilled PBST, followed by 1 hour of 
incubation on a rocking platform with anti-5xHis-Alexa647 antibody (diluted 1:1000 in 
PBST + 0.1% BSA).  The antibody solution was removed and the slides rinsed with chilled 
PBST, followed by 3 washes in PBST each 2 minutes with agitation.  The arrays were 
washed once more in chilled PBS for 2 minutes, then dried by centrifugation and scanned 
for fluorescence on a GSI Lumonix microarray scanner.   
 
4.4.3 Addition and characterization of photocrosslinking step 
LC-SDA (Thermo Scientific) was prepared as a 10 mM stock solution in DMSO 
immediately prior to use, then diluted either into water or pre-made metabolite solutions to 
the desired concentrations.  When photocrosslinking was desired during a hybridization, 
before removing the primary hybridization solution, the arrays were exposed to long-wave 
UV light (365 nM from an 8-watt lamp, at a distance of ~1 cm) for 20 minutes to allow the 
diazirine reaction to proceed.  Secondary hybridization and washes were then carried out 
as described above. 
 
4.4.4 Regulatory assay of chorismate mutase using N-acetylated regulators 
ARO7 was expressed from the MORF library9 as discussed in Chapter 2 and purified via 
immobilized metal ion chromatography, followed by cleavage of its ZZ-tag using 3C 
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protease and dialysis into PBS.  30 μL ARO7 at ~30 μg/mL was added to 15 μL of 10 mM 
chorismate and 15 μL of 1 mM of the appropriate amino acid, gently mixed, then incubated 
for 1 hour at 30 °C.  The samples were deproteinized using acetonitrile and analyzed via 
GC-MS as described in Chapter 2.   
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The work presented here explored the methodological requirements and realities of 
characterizing protein-metabolite regulatory interactions and of conducting other systems-
biological studies.  Ultimately, we contextualize previous work with new data and present 
a flexible-frame approach that addresses an aspect of regulatory characterization which is 
often inappropriately treated as an afterthought or presumed to already exist, as well as 
offering a discovery strategy that does not suffer from sensitivity or practical constraints in 
the manner seen for some other popular approaches.   
 
5.1.1 High-level insights from untargeted metabolomics1 
Metabolomics analysis of serum from inappetent, wild salmon versus fed, domesticated 
salmon during spawning did not seem to indicate that the inappetence of the wild fish 
resulted in a pathological state.  ω-9 free fatty acids were found to be accumulated in the 
inappetent group, contrasting the behavior of ω-3 fatty acids, which is a surprisingly 
specific structural point of divergence.  Accumulation of sugar alcohols was also observed 
in the inappetent group, which nothing currently known about salmonid metabolism can 
suggest an explanation.  These differences suggest potential value in the pursuit of related 
studies, which may ultimately aid in developing a firmer understanding of salmonid 
physiology and response to differing types of stress, and offer context and guidance for 




5.1.2 A pipeline framework for medium-throughput investigation of enzyme regulation 
via direct reaction assay 
Working with a published Saccharomyces cerevisiae protein library2, we developed a 
pipeline framework for use of in vitro reaction assays in validation/characterization of 
hypothesized regulatory interactions as well as de novo discovery of such interactions.  
Three enzymes with differing chemistries were selected for analysis in order to represent a 
part of protein diversity and assist in development of an experimental framework with the 
flexibility to handle that diversity.   
 
Given the large variation in both content and strictness of adherence to protocols for protein 
expression in literature, we conducted induction and expression time course assays for the 
three proteins of study.  While “efficiency” of expression (protein quantity versus overall 
biomass) was reduced in cultures that were allowed to proceed out of log-phase growth 
prior to induction, in general the differences observed across the range of the experiment 
indicated that the primary factor in the expression stage of such work can be convenience, 
rather than adhering to a strict window for induction.   
 
Different enzymes frequently have different requirements and sensitivities with regard to 
handling, and these differences can be problematic for studying many proteins in parallel.  
Enzyme reactivity was compared for the three proteins using a lysate preparation, fully-
purified protein, and an “on-bead” approach developed to provide a compromise between 
the benefits and drawbacks of the other two methods.  Each of the proteins investigated 
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had a different ideal assay structure due to differences in stability and the nature of the 
reactions themselves.   
 
Finally, we presented an iterative library-screening approach for regulator validation or 
discovery, demonstrating how one would efficiently narrow down from an arbitrary 
metabolite library to a regulator of the enzyme using ARO7 and its known regulators.   
 
5.1.3 Challenges and potential of small-molecule microarrays for interaction discovery 
Small-molecule microarrays3-5 are a “protein-first” method for identifying binding 
interactions between a protein and a potentially very large library of metabolites 
simultaneously, which we worked to adapt to the context of endogenous interaction 
discovery.  By using known (exogenous) binding pairs as positive controls, we were able 
to demonstrate sequential validation of the assay’s components, and identified guidelines 
for reducing background to suit the needs of using the assay primarily to screen for 
interactions on the weaker end of its detection range.   
 
As sensitivity was a substantial concern with regard to using the assay to screen for 
endogenous interactions, we attempted to implement a photocrosslinking strategy for 
“fixing” captured protein in place after the primary hybridization.  Final validation of the 
strategy was problematic due to a lack of appropriate positive controls, but it remains a 
potentially viable strategy for extending the sensitivity range of a small-molecule 




To test the hypothesis that the particularly small size of the metabolites we intended to 
begin working with (including tyrosine and tryptophan, whose interactions with ARO7 we 
were attempting to use as a positive control), we compared regulatory activity of N-
acetylated tyrosine and tryptophan to the unmodified amino acids via direct reaction assay.  
The lack of regulation by the substituted amino acids is evidence that SMMs may present 
more difficulties in searching for interactions in central metabolism than initially expected.   
 
5.2 Relevance 
Systems biology is fundamentally integrative in nature, taking information from multiple 
techniques aimed at various levels of metabolism.  At the highest level, the work presented 
in this thesis makes a practical argument in favor of a consciously multi-angled approach 
to studying metabolite-level regulation within one research group or project, as opposed to 
a search for the One True Platform.   
 
This work produced novel findings regarding salmonid metabolism, and how it may be 
affected by and/or tied to environmental factors.  The conclusion that inappetence likely 
does not involve a pathological state provides contrast to previous studies with other 
organisms, in turn highlighting future potential avenues of investigation that may uncover 
more physio-biochemical differences and increase understanding of all species involved.  
Furthermore, the results of the salmon inappetence study lay long-term groundwork for the 
potential pursuit of identifying metabolic biomarkers in one or more animals that can speak 




The methodologically-focused investigation of protein-metabolite regulatory interactions 
in this work via reaction assays and small-molecule microarrays directly contributes to the 
available toolbox of methods in the field of systems biology.  It also presents a critical 
evaluation of the practical realities of conducting these discovery efforts in a systematic 
manner, and strategic recommendations for the field moving forward.   
 
In order to conduct an effective, broad-range investigation of protein-metabolite 
interactions in an organism, it is important to have not only an effective set of assays, but 
a framework for handling large numbers of diverse proteins in the context of these assays.  
In previously-existing work on discovery methodology for protein-metabolite interactions, 
the protein-handling and validation steps are downplayed, with the focus placed squarely 
on assay development.  This work directly addresses those practical concerns using a 
widely-available protein library for a widely-studied, important model eukaryote, 
ultimately presenting a flexible pipeline that will be applicable to many future discovery 
efforts.   
 
As previously discussed, the wide variety of assays previously developed to identify 
binding interactions each have unique strengths and weaknesses that in turn are affected 
by the high level of variation observed in strengths and steric requirements of binding 
interactions.6 Very weak interactions present a particularly challenging problem for most 
of these strategies.  In some cases these strategies’ effective scopes are also limited by the 
need to chemically alter the binding partners in some way.  Both of these limitations are 
explored further in this work.  This highlights a gap in the available methodologies in the 
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context of medium-to-high-throughput studies, to which this work offers a compromise 
solution in the form of a medium-throughput direct reaction assay strategy.  This iterative 
library-screening method requires no alteration of either the proteins or the putative 
regulators, and its sensitivity is not limited by the need to directly detect metabolite 
binding, as no matter how weakly a regulator binds, if it does in fact regulate enzymatic 
activity, that is reflected in the assay result.   
 
Furthermore, this work takes steps to adapt a previously-established, potentially time- and 
resource-efficient, high-throughput detection strategy4 for protein-small molecule 
interactions in chemical biology to screen instead for endogenous binding interactions.  
Small-molecule microarrays have been previously shown to be an effective platform for 
identification of potential drug targets and leads.  In this work, we successfully replicated 
the technique and identified elements of the protocol that are particularly critical for the 
detection of interactions near the sensitivity limit of the assay.  We also developed a novel 
potential means of increasing the effective sensitivity of the assay, which, with further 
testing, may greatly facilitate the practical implementation of this technique for 
endogenous interaction discovery in the future.  Finally, we investigated the hypothesis 
that SMMs may not be an appropriate screening tool for a significant proportion of 
metabolism due to the likelihood of interfering with protein-metabolite binding when the 
metabolite in question is particularly small and has few functional groups that can attach it 
to the array.  The failure of chorismate mutase to be regulated by acetylated derivatives of 
its known regulators is evidence in favor of this hypothesis, which should further inform 




5.3 Recommendations for future study 
5.3.1 Small-molecule microarray assay development 
Despite the limitations identified in this work, small-molecule microarrays still offer a high 
degree of potential utility in regulator screening efforts if applied to an appropriate area of 
metabolism, and if sensitivity is improved.  Successful implementation of the technique 
across even a few classes of metabolites would allow for efficient identification of putative 
regulators in those sectors of metabolism for any species as long as correctly-folded protein 
can somehow be isolated.  
 
5.3.1.1 Additional reaction assays with substituted regulators 
The experiment presented in Chapter 4 wherein yeast chorismate mutase was shown not to 
be regulated by N-acetylated versions of its two known regulators offers evidence that the 
problem of hindrance due to array attachment might be of significant detriment to the 
assay’s effectiveness for very small metabolites.  Further investigation of SMM potential 
for endogenous interaction discovery should include repeating similar versions of that 
experiment with as many other known enzyme-regulator pairs as is practical.  (N-acetylated 
derivatives are available for many amino acids, and present a reasonable model for an 
array-attached amino acid, in particular, due to the fact that primary amines are among the 
most reactive functional groups with the isocyanate moiety used in the array attachment 
chemistry.)  These results will give much greater insight into the assay’s limits of 




5.3.1.2 Validation of photocrosslinking strategy for sensitivity improvement 
The roadblock reached in this work that caused us to shift focus away from development 
of the photocrosslinking technique was the lack of a conveniently-available, appropriately 
weakly-binding test case: no sensitivity increase could be observed when 
photocrosslinking capture was implemented with FKBP12-rapamycin binding, but this was 
ultimately unsurprising given the difficulty in stripping bound FKBP12 even under 
relatively extreme conditions.   Identification of an appropriate test case(s) will allow 
validation of the technique.  Proteins with known allosteric regulators in the micromolar 
affinity range (as the estimated sensitivity limit for these SMMs at present is on the order 
of 10 µM)3 should be tested with those regulators on an array; those whose binding is 
successfully detected to any degree present potentially appropriate candidates for 
photocrosslinking validation.   
 
When these candidate pairs are established, a series of hybridizations with different levels 
of wash stringency should be carried out using those pairs.  Any cases where signal can be 
easily attenuated by increasing the number or stringency of post-hybridization washes 
should then be used as test case pairs.  Hybridizations should then be carried out with 
photocrosslinking as described in section 4.4.3 and the fluorescence signal measured for 
various wash stringencies to characterize the effect of photocrosslinking on assay 
sensitivity.   
 
5.3.2 Integration of untargeted yeast metabolomics and regulator screening 
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Chapter 2 discusses the results of an untargeted metabolomics study in Atlantic salmon and 
points out the potential contextual relevance of such a study to regulator discovery and 
characterization.  Given that the remainder of the experimental work in this thesis was 
completed using yeast proteins and that the lab expects to continue studies with yeast, it 
would be highly appropriate to conduct yeast metabolomics studies, subjecting S. 
cerevisiae to environmental perturbations and using observed differences in metabolite 
abundances to guide a search for regulators making use of the other methods described in 
this thesis.   
 
5.3.2.1 Exploratory yeast metabolomics analysis 
S. cerevisiae cultures may be easily grown side-by-side, then subjected to differing 
environmental conditions at a given point in their growth and sampled for metabolomics 
analysis (via cold methanol quenching)7 both before and after the perturbation.  Specific 
perturbations that would be an appropriate starting point for an integrated study of 
regulation would be removal of key nutrients from the growth medium (via exchange into 
a dropout medium) or a change of carbon source.  Since protein-metabolite level regulation 
occurs on a fast timescale relative to other levels of metabolic regulation, samples should 
be collected immediately after the perturbation is applied, and once or twice more at short 
time intervals.  After all sampling is complete, quenched samples would be subjected to 
hot ethanol extraction7 followed by GC-MS analysis in the manner described in Chapter 2.   
 
5.3.2.2 Guided regulator search via iterative library screening 
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Our work with Atlantic salmon resulted in the identification of a small number of 
metabolites of different classes that were accumulated in inappetent fish.  With yeast in a 
nutrient deprivation experiment, the pathways involving accumulated metabolites would 
be similarly of interest.  Enzymes in such pathways would then be initial targets for library-
based reaction assay screening for regulator discovery.  Also, specifically, the results 
described in section 3.2.3 should be further pursued to investigate the possible existence of 
an as-yet unknown ARO7 regulator. 
 
5.3.3 Downstream mathematical modeling and bioinformatics analysis informed by 
regulator discovery 
Both the regulation data and the high-level metabolomics could subsequently be integrated 
into ongoing efforts within the lab to create dynamic mathematical models of yeast 
metabolism.  This would likely not be the work of one student, but a collaborative effort 
among a computational student pursuing yeast metabolic modeling strategies, an 
experimentalist investigating yeast metabolomics, and another with a focus on protein-
metabolite level regulatory interactions.  The latter researcher need not be working with 
yeast metabolism alone, as the discovery strategies discussed in this work are directly 
generalizable to any enzyme that can be practically overexpressed and/or purified, and 
work in phylogenetically-near homologues would potentially confer an additional, very 
exciting benefit: identification and sequence comparison of very close homologues with 
differing regulatory profiles could allow researchers to derive structural insight on protein-
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Detailed GCxGC-MS Methods 
 
AS Method 
An Agilent 7683 autosampler was used. Three pre-washes with pyridine were performed 
before each injection. The sample was then pumped into the syringe 4 times. The syringe 
size was 10 µL with a sample volume of 1 µL injected into the inlet. Three post-washes 
with pyridine were performed after injection. 
 
GC Method 
An Agilent 7890 gas chromatograph adapted to GCxGC analysis was used. The first 
column was an HP-5 30m x 0.320 mmID x 0.25 µm and the second was Rtx-200 2m x 
0.180 mmID x 0.20 µm. The excluded masses in auto mass defect mode option was chosen. 
Helium was used as the carrier gas with a corrected constant flowrate of 1.00 mL/min. An 
inlet septum purge flow of 3mL/min was chosen. The inlet was operated in splitless mode 
with a purge flow of 100 mL/min set to start 30 seconds after injection, yielding a total 
flow of 101 mL/min. Gas saver mode was used, with a flow of 20 mL/min set to start a 
minute after injection. 
 
The oven temperature program started at 50 °C for one minute and ramped to 295 °C over 
28 minutes followed by a 4.4 minute hold at 295 °C, with the secondary oven kept at an 
offset of 15 °C and the modulator temperature offset kept at 35 °C from the main oven. 
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Modulator times are presented in Table A.1. An equilibration time of 60 seconds was set 
for the ovens. The transfer line was set to 320 °C for the entire run. 
 
Table A.1: Modulation Timing 






1 Start 1128 4.00 0.50 1.50 
2 1128 1259.2 3.20 0.75 0.85 
3 1259.2 1315.2 3.50 0.75 1.00 
 
MS Method 
A Leco Pegasus IVD time of flight mass spectrum (TOF-MS) was used. The total MS 
method time was based on the GC method time. The acquisition delay was set to 400 
seconds, with the filaments being turned off until then. The collection mass range was from 
50 to 500 u. The acquisition rate was set to 200 spectra/second. The detector voltage was 
set to 100 V above the optimized voltage with the electron energy set to -70 V. The mass 
defect mode was set to manual with the mass defect 0 mu/ 100 u. The ion source 
temperature was 220 °C and the run had to wait for the ion source temperatures to reach 







Table A.2: Metabolite library lists 
15-compound 25-compound 50-compound 
(Tyrosine or tryptophan) (Tyrosine or tryptophan) (Tyrosine or tryptophan) 
  1-Methyl-L-histidine 
  2’-Deoxyuridine 
  2-Deoxyribose 5-phosphate 
 4-hydroxybenzoate 4-Hydroxybenzoate 
  4-Hydroxyphenylpyruvate 
  5-Phospho-D-ribose 1-
diphosphate 
Adenine Adenine Adenine 
  Adenosine-5-
monophosphate 
  Alanine 
 Anthranilic acid Anthranilic acid 
Arginine Arginine Arginine 
Asparagine Asparagine Asparagine 
Aspartic acid Aspartic acid Aspartic acid 
  Cysteine 
Cytosine Cytosine Cytosine 
  D-Glucuronic acid 
 D-Mannose D-Mannose 
GABA GABA GABA 
  Glutamine 
Glycine Glycine Glycine 
Guanine Guanine Guanine 
  Guanosine 
  Histidine 
  Homoserine 
  Isoleucine 
 Kynurenic acid Kynurenic acid 
  Kynurenine 
Methionine Methionine Methionine 
 Myo-inositol Myo-Inositol 
 Ornithine HCl Ornithine HCl 
 Orotic acid Orotic acid 
 Oxalic acid Oxalic acid 
  Oxaloacetic acid 
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Table A.2 (continued) 
Phenylalanine Phenylalanine Phenylalanine 
  Phenylpyruvate 
  Phosphoenolpyruvate 
  Proline 
Serine Serine Serine 
  Shikimic acid 
  Threonine 
  Thymidine 
Thymine Thymine Thymine 
Uracil Uracil Uracil 
  Uridine 
Valine Valine Valine 
  Xanthosine dehydrate 
  α-Ketoglutaric acid 
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